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CONSTRUCTING PEPTIDE (GEPI)-PROTEIN MOLECULAR HYBRIDS 
BY USING GENETIC ENGINEERING METHODS FOR MATERIALS AND 
MEDICAL APPLICATIONS 
SUMMARY 
For nearly two decades, molecular biomimetics makes the solid-binding short 
peptides available for nano-biotechnological applications. The new trend for 
selecting the GEPIs (Genetically Engineered Peptides for Inorganics) is the 
combination of experimental knowledge with bioinformatics tools to design GEPIs 
computationally. Combinatorially selected and then computationally enhanced silica 
binding peptide, QBP1, can be used as a TAG peptide for protein purification 
process. Affinity tags are highly effcient tools for purifying proteins from crude 
extracts. The selected peptide’s ability to bind strongly and specifically on silica 
material makes it a strong candidate to form a novel tag system for protein 
purification purposes. 
In nature, as a result of evolutionary selection processes, biological systems present a 
high degree of sophistication by having the advantage of using key 
biomacromolecules such as lipids, proteins and polysaccharides. Among these 
macromolecules, proteins with unique and specific interactions with other 
macromolecules and inorganics control the structures and the functions of all hard 
and soft tissues in organisms. Bones, teeth, shells, skeletal units and spicules are 
examples of hard tissues produced as biocomposites in many multicellular organisms 
and they are composed of not only minerals of different kinds, including 
hydroxyapatite, calcium and silica but also structural macromolecules, especially 
proteins. They are the key molecules to form the inorganics-organics hybrids to 
acquire different functionalities. The examples include; magnetic nanoparticles 
formed by magnetotactic bacterium (Aquaspirillum magnetotacticum) which helps 
the bacteria to use the gravity to move,  nanostructurally ordered thin film calcite on 
the outer layer of an S layer bacterium, Synechococcus strain GL24, that serves as a 
protective coating, mouse tooth enamel which is a hard, wear-resistant material with 
a highly ordered micro/ nano architecture consisting of hydroxyapatite crystallites 
that assemble into a woven rod structure.  
In these examples, biomaterials are highly organized from the molecular to the nano-
, micro- and macroscales with complex architectures that each hierarchical manner 
has its own different function. Their organization and formation are self-directed; 
their interaction with their surroundings is dynamic; their structures, functions, self-
healing in damage control are complex and their physical and chemical properties are 
multifunctional so their characteristics are difficult to achieve in purely synthetic 
systems. On the other hand, forming the similar nanotechnological systems in 
technology, have limitations in the synthesis and assembly into useful functional 
structures and devices. If harnessed well, novel engineering systems at nano-meter 
scale dimensions could have unique mechanical, electronic, magnetic and solution 
properties of nanostructured composites, low-dimensional semiconductors, single-
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domained particles and colloidal suspensions, respectively. Therefore mimicking 
nature has an enormous potential to achieve novel technological products and 
systems. 
Molecular biomimetics, mimicking the processes of biology at the molecular scale in 
materials formation for addressable structures and genetically tailorable properties, is 
a new approach for future bio-inspired materials. Such materials could be based on 
proteins binding to inorganics specifically and controlling their synthesis, formation 
and assembly so that these proteins can take place as integral parts of the final hybrid 
composite system.  
Molecular biomimetic approach has three solutions to the development of 
heterofunctional nanostructures:  DNA-based technology, molecular and nanoscale 
recognition and self-assembly. Therefore, for nano- and nanobiotechnology 
applications, in the control of assembly and formation of functional inorganic and 
hybrid materials and systems, inorganic binding polypeptides are used as molecular 
building blocks.. 
For obtaining inorganic binding peptides, there is a consensus on using combinatorial 
biological techniques. A large library of different peptides having same number of 
amino acids is created and screened if there is a specific sequence that binds an 
inorganic material of practical interest strongly. The final aim is to produce a 
molecular erector set promoting the assembly of complex, hybrid structures 
composed of inorganics, proteins and even functional polymers. The proteins and 
their binding characteristics can be manipulated by using DNA technologies. These 
short polypeptides are referred as genetically engineered proteins for inorganics 
(GEPI). Post selection engineering followed the experimental knowledge by using 
bioinformatics to design GEPIs computationally. Sequence similarity scores are 
assigned by using genetic algorithm procedures so that de novo structure predictions 
can be made and tuned-up GEPIs can be developed for the desired affinity and 
specificity. The engineered peptides are used as molecular manipulators for a wide 
range of applications. From the molecular tool box, a protein data bank is available 
with containing fully characterized GEPIs. Furthermore, GEPIs can be fused to 
functional proteins that lead to multifunctional protein based constructs to be used 
for many nanobiotechnological applications.  
In this part of the study, we used one of the second generation GEPIs (Quartz 
Binding Peptide, (QBP-1)), which was developed using computational tools based on 
the knowledge generated through phage display technology (first generation binder 
peptides). Genetically engineered vector systems with the required enzyme cleavage 
sites can make possible in vivo production of any desired peptide-protein construct. 
A peptide with specificity and affinity to a desired material, e.g., QBP-1, quartz 
binding peptide, can be linked to a desired functional biomacromolecule, such as 
laccases to form the molecular hybrid. The vectors can be used as hosts for the 
production of any other constructs just by changing either the peptide (ligand) or the 
protein (functional moiety). The selected peptide’s ability to bind strongly and 
specifically on silica material will be used to form a Tag system. And these fusion 
proteins will be tried to produce in large quantities in novel protein expression 
systems such as the newly called SilTag.  This system will be optimized to be a 
conventional method for the new coming GEPI and designer protein fusions.  
Laccases (EC 1.10.3.2) are lignolytic enzymes which carry two or four copper atoms 
per molekül.They are extracellular phenoloxidases with the ability to oxidize 
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phenolic substances by reducing molecular oxygen into water.  Laccases are key 
enzymes for many important industrial applications such as; detoxification of waste 
material from paper and textile industries, cleaning of herbicides and pesticides, 
water purification and production of cosmetic materials.  
In our research group, the expression of laccase gene from Pycnoporus sanguineus 
strain in Pichia pastoris was achieved. In this part of the project, QBP1 peptide 
(PPPWLPYMPPWS) is placed at the N terminus of the laccase enzyme (lcc1) in 
Pichia pastoris yeast cells to form a hybrid fusion molecule. Firstly, fusion protein 
was formed at DNA level and transformed into yeast cells, then the hybrid fusion 
was expressed at protein level. The activities of wild type enzyme (here, lcc1 laccase 
enzyme) and fusion protein were compared showing no significant effect of the tag 
peptide on laccase enzyme. For the next part of the study, QBP1 peptide is used as a 
“TAG” molecule for purification of fusion molecule through silica/ quartz packed 
columns. 
Overall, what we are showing here is that Molecular Biomimetics and bioinformatic 
tools, collectively, offer a good way of designing our own tag peptide for purification 
purposes with increased properties such as using cheaper material and single step 
easy purification protocols.    
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MALZEME ve MEDİKAL UYGULAMALAR İÇİN GEN MÜHENDİSLİĞİ 
YOLUYLA PEPTİD (GEPI)- PROTEİN HİBRİTLERİN OLUŞTURULMASI 
ÖZET 
Doğada, milyonlarca yıl süren evrimsel süreçler sonucunda, lipidler, polisakkaritler 
ya da proteinler gibi biyomakromoleküller yüksek seviyede sofistike olmuş 
sistemlerin oluşmasını sağlamıştır. Oluşan bu sistemlerle canlılar, zorlu çevre 
şartlarına daha iyi uyum sağlamanın yollarını keşfetmişlerdir. Bu 
biyomakromoleküller arasında proteinler özel bir öneme sahiptir. Proteinler diğer 
makromoleküller ve inorganikler ile tepkimeye girerek tüm sert ve yumuşak 
dokuların yapısında bulunurlar ve tüm fonksiyonların çalışmasında etkili olurlar. 
Kemikler, dişler, deniz kabukları ve iskeletler, proteinlerin diğer organik ve 
inorganik moleküllerle birlikte çalıştıkları örneklerdir. Bu yapılarda yer alan 
proteinler sadece organik moleküllerle değil, aynı zamanda inorganik moleküllerle 
de bağ yaparak değişik fonksiyonel özelliklerin kazanılmasını sağlarlar. Örneğin, 
magnetotaktik bakteride (Aquaspirillum magnetotacticum) hücre içerisinde inorganik 
nanoyapılar bakterinin yerçekimi yardımı ile hareketini sağlar. Diğer bir örnek olan 
S-layer bakterisi (Synechococcus strain GL24) yüzeyinde oluşan kalsit tabaka 
koruyucu bir yapıdadır. Benzer şekilde fare dişindeki enamel, hidroksiapatit 
kristallerinden oluşan ve dişe hem esneklik hem dayanıklık sağlayan bir yapıdır.  
 
Bu örneklerde görülen, nano boyuttan makroya, yüksek derecede organize olmuş 
yapılar hiyerarşik bir şekilde oluşmuşlar ve inorganik moleküller ile organik 
moleküller birlikte rol almışlardır. Evrimsel süreçler sonucunda elde edilen bu 
fonksiyonlar ile canlılar çevresel şartlar karşısında avantaj elde etmişlerdir. 
  
Diğer yandan, doğada gözlemlenen bu tür fonksiyonel yapıların endüstride ve 
teknolojide yeniden yapılması son derece zorlu bir süreçtir. Bu yapılar detaylı 
incelendiğinde, proteinlerin düzenleyici, kontrol eden, bir araya getiren özellikleriyle 
bu yapıların oluşmasının temelinde olduğunu görüyoruz. O halde bu tür fonksiyonel 
özellikleri elde edebilmemiz için, inorganiklere seçici olarak bağlanabilen proteinleri 
kullanabiliriz. 
 
Moleküler Biyomimetik doğada moleküler seviyede gerçekleşen süreçleri izleyerek, 
benzer sistemleri oluşturmayı ve fonksiyonel sistemler kurmayı amaçlar. Canlıların 
milyonlarca yıl süren evrimsel süreçlerle elde ettikleri yararlı fonksiyonların 
gözlenmesi ile benzer fonksiyonel sistemler laboratuvar ortamında elde edilebilir.  
Moleküler Biyomimetik’in temelini de inorganiklere spesifik olarak bağlanabilen 
peptidlerin bulunması ve uygulamalarda kullanılması yatar.  
 
İnorganiklere spesifik olarak bağlanabilen peptidlerin bulunması için aşamalı bir yol 
izlenmesi genel kabul görmektedir. Öncelikle, kombinatoryel biyolojik teknikler (faj 
gösterim, hücre yüzey gösterim metodları vb.) yoluyla istenilen inorganik 
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malzemeye spesifik peptidler bulunur ve bağlanma dereceleri sınıflandırılarak 
optimize edilir. Devamında ise, deneysel verilerden elde edilen bilgiler ışığında, 
biyoinformatik yöntemler ve benzerlik analizleri yoluyla daha iyi bağlanabilen 
peptidler elde edilir ve bu peptidler de test edilerek bağlanabilirliği kontrol edilir.  
 
Bu çalışmada kullanılan QBP1 peptidi 12 amino asit uzunluğunda ve kuartza 
bağlanabildiği deneysel çalışmayla gösterilmiş dizilerin biyoinformatik işlemden 
geçirilmesi sonucunda ortaya çıkarılmıştır. QBP (Quartz binding peptid), kuartza 
seçici olarak ve yüksek afinitede bağlanabilen 12 amino asit uzunluğunda bir 
peptidtir. Kuartz yüzeyine bağlanabilme özelliği sayesinde, istenilen bir protein 
QBP1 yoluyla kuartz yüzeyinde sabitlenebilir. Ancak bunun için ilk yapılması 
gereken, DNA seviyesinde QBP1 peptidinin dizisini iatenilen proteinin DNA 
dizisine eklemektir. Burada QBP1 peptidini AP (alkalin fosfataz) enziminin N-
terminal ucuna eklendi. Protein üretilmesi aşamasında ise, bakteri hücresi kullanıldı 
ve sonuçlar optimize edilmeye çalışıldı. Burada amaçlanan, QBP1 yoluyla istenilen 
bir proteinin kuartz yüzeyine bağlanabileceğini ve uygulamalar açısından kullanışlı 
olacağını göstermektir. Ancak dikkat edilmesi gereken en önemli konuların başında, 
bakteri hücresinde protein üretimi sırasında meydana gelebilecek sıkıntılardır. 
Projemizde 2. jenerasyon GEPI’ler (Kuartza bağlanabilen peptidler, QBP-1) 
kullanıldı. Bu peptidler grubumuzda daha önceden faj gösterim metodu ile elde 
edilen 1. jenerasyon QBP’lerin biyoinformatik yöntemlerle işlenmesi sonucu elde 
edildi (1). Kuartz yüzey üzerine seçici olarak bağlanmada diğer QBP’ler arasından 
öne çıkan QBP-1 bu çalışma için seçildi. QBP-1 ile herhangi bir fonksiyonel molekül 
DNA seviyesinde biraraya getirilerek hibrid moleküller oluşturulabilir ve QBP-1’in 
kuartz yüzeyine seçici olarak bağlanabilme özelliğinden yararlanılarak istenilen 
molekülün fonksiyonel özellikleri kullanılabilir.  
Lakkazlar (EC 1.10.3.2) ligninolitik enzimler olarak molekül başına iki ya da dört 
bakır atomu tasıyan ve fenolik maddeleri moleküler oksijeni suya indirgeyerek 
okside edebilme özelligi olan ekstraselüler fenoloksidazlardır. Kagıt ve tekstil 
sanayiinden gelen endüstriyel atıkların detoksifikasyonu gibi çesitli biyoteknolojik 
süreçlerde çok önemli uygulamaları bulunan enzimler olup, herbisit ve pestisitlerin 
temizlenmesi, belli su saflastırma sistemleri için temizleme ajanları ve kozmetik 
malzemesi olarak da kullanılabilmektedir (2,3,4). Grubumuzda Pycnoporus 
sanguineus suşundan elde edilen lakkaz geninin Pichia pastoris’te ekspresyonu 
sağlanmıştır. Projenin bu kısmında ise, QBP1 peptidi (PPPWLPYMPPWS), Pichia 
pastoris maya hücrelerinden elde edilen lakkaz (lcc1) enziminin N-terminal ucuna 
yerleştirilerek füzyon protein oluşturuldu. Öncelikle DNA seviyesinde oluşturulan 
füzyon protein Pichia pastoris hücrelerinde üretildi. Oluşturulan füzyon protein ile 
lcc1 enziminin aktiviteleri karşılaştırılarak, QBP-1 peptidinin bağlanmış olduğu 
enzim aktivitesi üzerine etkisi ortaya konuldu. QBP1 peptidi, N-terminale bağlı 
olduğu halde, enzim aktivitesinde değişikliğe neden olmamaktadır. Bu ise bir “tag” 
molekülü olarak QBP1 için oldukça avantajlı bir özelliktir. Yapılacak uygulamaya 
göre, saflaştırma sonrasında tag molekülü, enzim ile bağlı olarak bırakılabilir. 
Çalışmanın devamında QBP-1 peptidi bir “tag” peptid olarak görev yaptırılarak 
hücre ortamından füzyon proteinin saflaştırılmasında kullanılmıştır. Hazırlanan 
kuartz kolonlar ve batch sistem yollarıyla, QBP-1’in kuartz yüzeyine bağlanabilme 
özelliği kullanılarak füzyon proteini hücre ortamından saflaştırmak mümkün 
olmuştur. 
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Sonuç olarak burada, Moleküler Biyobenzetim ve biyoinformatik tekniklerinin 
birlikte kullanılmasıyla, daha ucuz ve basit saflaştırma yöntemleri geliştirme amaçlı 
yeni TAG moleküllerinin elde edilebileceğini göstermiş oluyoruz. Kuartza seçici 
olarak bağlanabilen QBP1 peptidi, sahip olduğu özellikler sayesinde, mevcut ticari 
“tag” (afinite etiketi) sistemleri ile rekabet edebilecek bir tag molekülüdür.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
xxviii 
 
 
 
 
 
 
1 
1.  INTRODUCTION AND BACKGROUND 
1.1 Inorganic-binding Proteins and Their Importance in Organismal       
Biomineralization 
 As the main building material of the cell, proteins do most of a cell’s work. Through 
their unique and specific interactions with other macromolecules and inorganics, they 
control the formation of cellular structures and functional activities in the biological 
tissues. Soft (Kaplan et al., 1994) and hard (Lowenstam and Weiner, 1989) tissues, 
as the main biological tissues in which the proteins do most of the work, have very 
organized structure from molecular to the nanoscale. Soft tissues are the biomaterials 
containing only organic part as in the cases of muscle, membranes, skin, tendon, 
spiders’ silks, and cuticles and they are of great interest in soft tissue engineering 
(Kaplan et al., 1994, Sakiyama and Hubbell, 2001).  
On the other hand, hard tissues contain organic-inorganic hybrid systems 
(Lowenstam and Weiner, 1989, Mann, 1996) such as bones, dental tissues (i.e., 
dentine and enamel), spicules, spines, shells, skeletal units of single-celled organisms 
(e.g., radiolarian) or plants, bacterial thin film, and nanoparticles (Lowenstam and 
Weiner, 1989, Mann, 1996).  For more than 3 decades, they have been an inspiration 
for materials design and engineering due to their key properties. They have an 
architectural organization from molecular to nano-, micro-, and macro-scales which 
have often been formed in a hierarchical manner, with very complex nano-
architectures and infinite number of functional diversity. They are ‘‘smart,’’ 
dynamic, complex, self-healing, and multifunctional. At the center of all these hard 
tissues, there is a common proteinaceous phase working as the main organizer of the 
system. 
After hundred thousands years of evolutionary processes, nature has built abundant 
examples of materials and systems where inorganics and organics have met for 
improved and refined properties. Figure 1.1 shows three examples of naturally 
occuring organic-inorganic hybrid material formations in different species. The first 
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one is a single-celled bacteria called Aquaspirillum magnetotacticum that 
incorporates a magnetic nanoparticle system (Figure 1.1A). The bacteria forms 
magnetic nanoparticles which are magnetite (Fe3O4) formed as perfect cubo-
octahedral single crystals, about 50 nms. in diameter. About 25 nanoparticles align 
within the cell to to create a magnetic moment large enough to sense the Earth’s 
magnetic field.  
The second one is mother-of pearl of seashells, the natural armor of mollusks (Figure 
1.1B), which has a layered shell structure in the form of CaCO3 and biopolymer 
mixture (proteins and polysaccharides). The soft and hard component phases in the 
shell structure gives the necessary toughness and fracture strength for the organism’s 
protection. 
The third one is a mammalian tooth (Figure 1.1C). One of its tissues is enamel which 
is the hardest material in the body, protecting the tooth. Under the enamel, there is 
dentin layer which is softer and absorbs the stress during chewing.  A group of 
proteins control the formation of ordered fibers of 3 microm-diameter enamel rods, 
each consisting of thousands of 30 nm-diameter, mm-long, and crystallographically-
aligned elongated hydroxyapatite (HA) crystallites. This organics-inorganics hybrid 
structure prevents premature fracture or failure.  
All these examples of hybrid systems are coming from the organisms which have 
naturally found the ways to use some of their proteins to produce and bind the 
inorganic materials in vivo, and then use these excellent systems for their benefit. 
This systems are formed through years of evolutionary processes in aqueous 
environments under mild physiological conditions to perform excellent functions 
such as forming protective layers, supportive tissues, transferring charge and ion, 
developing some optical and mechanical properties. The key molecule to form such 
functional systems is proteins with indispensable properties in every process within 
the cells such as working for mineralization, serving as enzymatic catalysts, being a 
usefull transport and storage molecules, mediating cell responses, being active in 
immune protection and cell differentiation. By observing the functions of the 
proteins in nature, we can genetically engineer polypeptides to specifically bind to 
selected inorganic compounds to form hybrid materials to get excellent functions for 
applications in nano- and biotechnology. (Sarıkaya and Aksay, 1995, Mann, 1996, 
Lowenstam and Weiner, 1989). 
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Figure 1.1: Examples of biologically synthesized organic-inorganic hybrid materials 
with a variety of physical properties: (A) Single-crystalline, single-
domained magnetic magnetite nanoparticles (Fe3O4) formed by a 
magnetotactic bacterium (Aquaspirillum magnetotacticum) (inset: higher 
magnification image of the magnetite nanoparticles revealing cubo-
octahedral particle shape). (B) Nacre, mother-of-pearl is a segmented 
laminated composite of calcium carbonate and biomolecules having 
mechanical properties that provide an armor to the mollusks such as red 
abalone, pearl oyster, and nautilus. (C) Mammalian tooth is a hierarchical 
multimaterial system composed of enamel (e), dentin (d), pulp (p), 
cementum (c) and periodontal ligaments (PDL). Enamel, such as the one 
shown here from mouse, is ~100% hydroxyapatite crystals that have a 
hierarchically ordered woven structure providing stability against 
complex mastication mechanical stresses. (Sarıkaya et al., 2010). 
1.2 Applications of Inorganic-binding Proteins in Nano and BioTechnology 
For decades, traditional approaches try to overcome the limitations of nano-
technological systems. The difficulty in the synthesis of nano-technological systems 
and their assembly into useful functional structures and devices prevents us to benefit 
from the full potential of nanotechnology in sciences and technology. Synthesis of 
nanoscale materials by traditional approaches such as melting and solidification 
processes, followed by thermo-mechanical treatments, or solution/vacuum deposition 
and growth processes (DeGarmo et al., 1988), is inefficient, requiring stringent 
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conditions such as high heat and pressure, and often producing toxic byproducts 
(Niemeyer, 2001, Sarıkaya et al., 2003). Even most advanced micro and 
nanotechnology processes have the limitations of large scale synthesis of complex 
nano-scale architectures. The problem of scaling-up in nanotechnology is still 
standing against traditional approaches. The product is so small in quantity and not 
reproducible because of nonspecific interactions and uncontrolled agglomeration. 
Even today’s one of the most successful nano-technological systems, carbon nano-
tubes, have the same kind of limitations such as uncontrolled surface chemistry, and 
difficulties in multidimensional assembly for the widespread use (Harris, 1999).  
For the control and production of large scale nano-structures, practical strategies are 
needed (Schmid, 1994). Observing and analyzing the examples from the nature can 
show the way to find those strategies. As exampled in Figure 1.1, the nature itself 
produces ordered and complex nanostructures where inorganic materials are 
synthesized in aqueous environment under mild conditions such as ambient 
temperature, pressure and neutral pH. Magnetite (Fe3O4) particles in magnetotactic 
bacteria or teeth of chiton (Frankel and Blakemore, 1991); silica (SiO2) as skeletons 
of radiolarian (Lowenstam and Weiner, 1989) or tiny light-gathering lenses and 
optical wave guides in sponges (Fong et al., 2000); hydroxyapatite (Ca2C(OH)3) in 
bones (Glimcher and Nimni, 1992) and dental tissues of mammals (Paine et al., 
2000); calcium carbonate (CaCO3) in the shells of mollusks as armor (Mayer and 
Sarıkaya, 2002) or as thin protective films in some species of S-layer bacteria 
(Schultze et al., 1992); and spines and tests of sea-urchins (Lowenstam and Weiner, 
1989) are all examples of natural occurring nanostructures and hard tissues where a 
proteinaceous phase is active in the synthesis (Sarıkaya, 1999). In all these examples, 
proteins are the workhorses that control the fabrication of biological structures by 
orchestrating the assembly of materials in two and three dimensions. 
1.3 Obtaining Inorganic-binding Proteins 
To get the similar functional properties as shown in Figure 1.1, we need to somehow 
produce or get inorganic binding polypeptides. There are several possible ways to 
obtain the proteins or polypeptides, specific to inorganic substances. Some of them 
are naturally occurring inorganics-binding proteins such as ice-binding (antifreeze) 
proteins which are synthesized in many fish species, plants, and insects (Liou et al., 
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2000). They bind to ice in the internal fluids of the organisms and control particle 
size, morphology, or disruption. The examples in Figure 1.1 are systems in which 
naturally occuring proteins are used to form inorganic material in vivo and then the 
organism uses these inorganics for its benefit. First way of having inorganic-binding 
polypeptides such as the examples given before, is to extract biomineralizing 
proteins from hard tissues, followed by purification and the cloning of their genes. So 
far, several proteins isolated in this fashion. They have been used as nucleators, 
growth modifiers, or enzymes in the synthesis of certain inorganics (Cariolou and 
Morse, 1988, Paine and Snead, 1996, Berman et al., 1988, Weizbicki, 1994, Kroger 
et al., 1999, Cha et al., 1999). Amelogenins in mammalian enamel synthesis (Paine 
and Snead, 1996); silicatein, in sponge spicular formation (Cha et al., 1999); and 
calcite- and aragonite-forming polypeptides in mollusk shells (Cariolou and Morse, 
1988, Berman et al., 1988, Weizbicki et al., 1994) are the examples for that case. 
The problem with this way is the limitations with the extraction process and further 
analysis steps. It is difficult and time consuming. Limited number of known naturally 
occuring proteins is another drawbacks for this way of getting inorganics-binding 
polypeptides. 
Another way of obtaining inorganic-binding peptides is designing them using a 
theoretical molecular approach similar to those employed for the design and 
development of pharmaceutical drugs (Schneider and Wrede, 1998, Schonbrun et al., 
2002). But that is currently impractical and too expensive for current materials 
research.  
Finally, there is a consensus on using another way of obtaining such inorganic 
binding peptides which are referred as genetically engineered proteins for inorganics 
(GEPI) (Sarıkaya et al., 2004). This way is using combinatorial biological techniques 
(Sarıkaya et al., 2003, Naik et al., 2002) which is basically using a large library of 
different peptides having same number of amino acids to screen if there is a specific 
sequence that binds an inorganic material of practical interest strongly. This 
technology have been used for more than two decades for obtaining organics-binding 
peptides and been adapted for selection of inorganics-binding peptides. 
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1.4 Molecular Biomimetics 
Combination of traditional physical and biological fields brings us a new field called 
molecular biomimetics. It is an emerging field where assembly of hybrid materials 
can be achieved at the molecular scale using the specific recognition properties of 
proteins. Its essence is basically mimicking the processes of biology at the molecular 
scale. The ability of recognition and specifically binding to inorganics makes the 
proteins to form inorganic-organic hybrid materials which form the base for this new 
field (Sarıkaya et al., 2003, Ball, 2001). 
Three basic solutions are offered by molecular biomimetics for the problem of 
control and fabrication of large-scale nanostructures and ordered assemblies of 
materials in two and three dimensions as schematically. The new field offers three 
unique advantages derived from Nature. 
The first, complex nano-, and possibly hierarchical structures, similar to those found 
in nature (self-assembly) can be formed by using the ability of biological molecules 
to self- and co-assemble into ordered nanostructures. The ultimate goal of molecular 
biomimetics is to generate a molecular erector set in which different proteins, each 
engineered to bind to a specific surface, size, or morphology of an inorganic 
compound, promote the assembly of intricate, hybrid structures composed of 
inorganics, proteins, and even functional polymers (Sarıkaya et al., 2003). Some 
potential acting ways of inorganic-binding proteins are exampled in Figure 1.2. 
Secondly, synthetic entities, including nanoparticles, functional polymers, or other 
nanostructures can be bind onto molecular templates where the molecular and 
nanoscale recognition by the use of surface specific proteins are effective. In this 
step, the protein template is the linker or in other words “molecular erector sets” to 
join synthetic entities and the inorganic surface which the protein template is 
specific.  
Final one is designing the protein templates through genetics at the molecular level. 
This is DNA-based technology and inorganic binding peptides and proteins are 
selected and designed. The designed protein template is the result of the DNA which 
codes for that protein.   
Current progress in the field points to a possible beginning of a new era where 
biological principles are not only used in designing materials which mimic the 
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properties of biological counterparts, but also to take advantage of the functions and 
underlying principles of biomolecular processes to produce novel materials, systems 
and fabrication techniques that exhibit exquisite sensitivity, and accuracy, self 
healing, adaptability, control and, even, self replication.  
 
Figure 1.2: Potential uses of inorganic-binding polypeptides. (a) linkers for 
nanoparticle immobilization, (b) functional molecules that assemble 
on specific substrates, and (c) heterofunctional linkers involving two 
(or more) binding proteins adjoining several nanoinorganic units. 
NSL, nonspecific linker (Sarıkaya et al., 2004). 
1.5 Peptide Display Technologies 
Development of combinatorial selection techniques more than two decades ago led to 
enormous progress in the characterization of antibody-receptor, protein- or 
peptideligand interaction for a myriad of biotechnological and biological 
applications. Among them, phage (Smith et al., 1997) and cell surface displays 
(Boder et al., 1997, Lu et al., 1997, Brown et al., 2000)   have been widely used. 
Both of the techniques rely on the link between phenotype and genotype of the 
organisms. Random peptide sequences that are encoded in either phage genome or 
plasmid bacterial DNA are displayed within the context of proteins localized on the 
surface of the phage particle or the cell, respectively. Outer membrane proteins, 
lipoproteins, fimbriae and flagellar proteins have been used to display the 
randomized peptide library on surface of bacteria,5 while phage display utilizes the 
major or minor coat proteins of bacteriophage M13 to display the random peptides 
on the virus surface. 
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Phage display (PD) (Smith, 1985, Hoess, 2001) and cell-surface display (CSD) 
(Wittrup, 2001) are well-established in vivo display techniques for the isolation of 
polypeptides capable of binding inorganic materials with high affinity. They have 
been used to screen and identify various biological activities, such as catalytic 
properties or altered affinity and specificity to target molecules in many applications 
including the design of new drugs, enzymes, antibodies, DNA-binding proteins and 
diagnostic agents (Rosander et al., 2002, Petrouna et al., 2000, Smith and Petrenko, 
1997, Benhar, 2001). Ribosomal and messenger RNA display technologies are the 
main in vitro methods (Amstatz et al., 2001) which have been developed for 
increased library size (10
15
) compared to those of in vivo systems (10
7–1010).  
1.6 Adaptation of Combinatorial Techniques for the Selection of Inorganic-
binding Proteins  
To use display techniques for selecting inorganic-binding polypeptides, 
combinatorial selection procedures were adapted and optimized for the organic-
inorganic interaction. Among biocombinatorial in vivo and in vitro methods, phage 
and cell surface displays became the predominant tools for material-specific peptide 
selection.  
In the standard biopanning round, the library of phage or cell clones, displaying a 
vast population of randomized peptides on their surfaces, is exposed to inorganic 
targets. Spectroscopic and imaging techniques were used to characterize inorganic 
surfaces before and after biopanning rounds to detect any change on the surface (Dai 
et al., 2004). If evidence of surface modification is obtained, buffer conditions 
should be optimized to guarantee compatibility with the target inorganic. The effect 
of the conditions in the rounds on the biological materials, phages or bacteria, need 
also be optimized. In general, a large, random library of peptides with the same 
number of amino acids, but of different sequence compositions, is screened to 
identify specific sequences that strongly bind to a chosen inorganic material surface. 
There is no need for a priori knowledge of the desired specific polypeptide or single 
amino acid. The specific polypeptide sequence is simply selected and enriched. 
In Figure 1.3, the adaptation of in vivo display techniques, phage display (PD) and 
cell surface display (CSD), is simply presented. In these techniques, libraries are 
generated by inserting randomized oligonucleotides within certain genes encoded on 
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phage genomes (Whaley et al., 2000, Naik et al., 2002) or on bacterial plasmids 
(Brown, 1997, Schembri et al., 1999, Brown et al., 2000) (step 1 in Figure 1.3). 
When the libraries are created, a random polypeptide sequence is incorporated within 
a protein on the surface of the selected organism. This protein is a coat protein of a 
phage for phage display selection procedure or an outer membrane or flagellar 
protein of a bacterial cell for cell surface display selection methodology; (step 2). 
The peptide is displayed randomly on each phage or cell, and different than others 
(step 3). The next step is introduction of the random peptide library which contains a 
heterogeneous mixture of recombinant cells or phages, and the selected inorganic 
substrate (step 4). After several washing cyles, non-binder cells or phages are 
eliminated. The weak interactions with the substrate and the cells or phages are 
disrupted via washing buffers (step 5). Better binders stay on the surface and can be 
eluted by using strong buffers (step 6). The eluted phages are amplified by 
reinfecting the host in phage display (step 7); on the other hand, in cell surface 
display, cells are allowed to grow (steps 7, 8). This is the end of a round of 
biopanning which is generally repeated 3-5 times to to enrich the population with 
clones having high-binding affinity to inorganic solid targets. 
In the final step, individual clones from the selected bound pool are isolated and 
binding peptide sequences are identified (step 9) by DNA analysis of the phage 
genome (Figure 1.3). The advantage of the bacterial cell surface display system over 
phage display library is its greater efficiency in generating peptide sequences, simply 
because of the fact that the former does not need a second host organism to amplify 
and replicate genomic and plasmid sequences. 
Since the adaptation of combinatorial techniques for obtaining inorganic-binding 
polypeptides, many short peptide sequences have been identified for inorganic 
targets including noble metals; Au (Lu et al., 1995, Huang et al., 2005), Ag (Naik et 
al., 2002, Nam et al., 2008), Pt (Seker et al., 2007), oxides; SiO2 (Oren et al., 2007), 
ZnO (Thai et al., 2004), Cu2O (Thai et al., 2004), TiO2 (Dickerson et al., 2008, 
Sano et al., 2005, Sano et al., 2003), minerals; hydroxyapatite (Gungormus et al., 
2008), calcite (Gaskin et al., 2000), graphite, sapphire (Krauland et al., 2007) and 
semiconductors; GaN (Whaley et al., 2000), ZnS and CdS (Lee et al., 2002).  
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Figure 1.3: Phage display and cell-surface display. Principles of the protocols used  
for selecting inorganic binding polypeptide sequences (Sarıkaya et al., 
2004). 
All these binders have been used in the proof-of-principle synthesis, morphogenesis 
and assembly of inorganics, finding practical applications in a wide ranging and 
diverse areas of nanotechnology and medicine (Sarikaya et al., 2004, Naik et al., 
2002). 
1.7 Computational Selection Methodology: Combining Experimental 
Knowledge with Bioinformatics 
The new trend for selecting the GEPIs is the combination of experimental knowledge 
with bioinformatics tools to design GEPIs computationally. The inspiration for this 
trend is coming from evolutionary biology. As we know from the examples of 
nature, there is a correlation between the sequence and the function. Having similar 
sequences usually means performing similar functions due to biochemical, 
biophysical and evolutionary constraints.43. Combining Experimental Knowledge 
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with Bioinformatics is a general one and can be used to design new sequences that 
bind to a given inorganic solid with predictable and enhanced affinity (Oren et al., 
2007).  
To do that, as shown in Figure 1.4 (Tamerler et al., 2010),  GEPIs are selected 
experimentally and characterized so that they are grouped into three sequence 
clusters, i.e., strong, moderate and weak, according to their material-binding 
affinities. Then, this experimental knowledge is combined with sequence alignment 
methods (Needlema et al., 1970, Smith et al., 1981) and the standard scoring 
matrices (Henikoff et al., 1992, Dayhoff et al., 1978), to generate a novel material 
specific sequence scoring matrix (Oren et al., 2007) that would account for the 
specific sequence patterns responsible for binding. So that, de novo structure 
predictions can be made and finally, tuned-up GEPIs can be developed for the 
desired affinity and specificity. To design high affinity GEPIs, random sequences can 
be generated and by using scoring matrixes their sequence similarities can be 
compared to the experimentally known strong binding sequences.  
Different material specific matrices can be combined for the selection of GEPIs with 
multiple inorganic material recognition and binding functionalities (Figure 1.4) 
(Tamerler et al., 2009).  
 
 
 
Figure 1.4: Knowledge based approach for generating next generation of peptides 
with better binding properties. (Tamerler et al., 2010). 
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1.8 Current and Potential Applications of Inorganic Binding Peptides (GEPIs) 
Among the others, two review papers (Tamerler et al 2008, 2010) which were 
published by our research group summarize the current and potential applications of 
inorganic binding polypeptides (GEPIs). They can be usefull for a wide range of 
applications at the core of nano-technology (Drexler et al. 1994), bio-
nanotechnology (Niemeyer et al. 2001), as well as biological materials science and 
engineering.  
Firstly, GEPIs are assemblers and linkers. Functional nano particles, proteins as well 
as organic dyes can be immobilized onto specific inorganic surfaces by using 
inorganic binding peptides. (Krauland et al. 2010, Zin et al. 2007, Kacar et al. 2009, 
Zin et al. 2005, Park et al. 2006).    
GEPIs provide the self assembly of the nano-components on the surface for various 
applications, e.g., protein immobilization, biosensing, microarray fabrication. Two 
basic properties of GEPIs make them suitable for this type applications: which are 
their high affinity and material specificity. ( Sarikaya et al. 2003, Brown et al. 1997, 
Tamerler et al. 2006). 
Figure 1.5 shows an example of using GEPIs to directly assemble a nanoparticle on a 
micropatterned substrate composed of multimaterial regions, e.g. gold, platinum, 
silica (Tamerler et al. 2010). Gold binding peptide (AuBP), three repeats of a 
platinum binding peptide (3R-PtBP) and a quartz binding peptide (QBP) were used 
in immobilization of streptavidin-coated quantum dots (SAQD) that emit red light 
under the fluorescence microscope (FM).  
They can also be used as as ink and printed onto the solid surfaces specifically using 
different lithography techniques, e.g., soft lithography (Zin et al. 2007, Kacar et al. 
2009) and dip-pen lithography (Zhao et al. 2006). GEPIs can be chemically linked to 
other linker molecules too, e.g., biotin (Figure 1.5) and organic molecules, e.g. FITC.  
Secondly, GEPIs are used as molekuler linkers in biomaterial applications. They bind 
quite strongly to their respective materials. Several of them have already been shown 
to form densely packed monolayers in entirely aqueous solutions under ambient 
conditions (e.g., pH *7.0). So that, they are uniquely suited for modification of 
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biomaterial surfaces. Bioactive and bioinert surfaces can be created via GEPI linkers 
on a number of materials.  
 
 
 
Figure 1.5: Use of GEPI as linker for preferential assembly of SA-QD on different 
inorganic surfaces. The substrates composed of either Pt and Au or only 
micropads on silica were incubated with either AuBP-bio (A), or 3R 
PtBP-bio (B) or QBP-bio (C). After the procedure schematically shown 
for each peptide was carried out the substrates were examined under 
FM. (Tamerler et al. 2010). 
Figure 1.6 shows immobilization of RGD integrin-binding sequence on silica glass 
using QBP1 peptide for bone grafts and other tissue-integrated applications.  
Thirdly, using GEPIs is a practical approach in biomineralization purposes for 
restorative and regenerative tissue engineering. GEPIs have been a usefull agent in 
fabrication of inorganic substrates, templated conjugates, production of protein-
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encapsulated particles and controlled synthesis of nano-particles and minerals 
(Gungormus et al. 2008, Gaskin et al. 2000). Besides these peptides can be utilized 
to control the formation of biologically important hard tissues, i.e., bone and teeth. 
 
 
 
 
 
Figure 1.6:(A) Light optical microscopy images of NIH3T3 fibroblast cells (3 3 105 
cells, 1.5 hrs, 2003) on gold substrate modified with GEPI-PEG 
conjugate; (B) Scanning electron microscopy (SEM) images of NIH3T3 
(5 3 103 cells, 24 hrs) on glass substrate modified with GEPI-RGD 
conjugate; (C) SEM images of NIH3T3 (83 104 cells, 24 hrs) on titanium 
surface modified with GEPI-RGD conjugate.  
Additionally, GEPIs can also be used as as ink and printed onto the solid surfaces 
specifically using different lithography techniques, e.g., soft lithography (Kacar et al. 
2009, Zin et al. 2007) and dip-pen lithography (Zhao et al. 2006). They can be 
chemically linked to other linker molecules too, e.g., biotin and organic molecules, 
e.g. FITC.  
1.9 TAG Technology-Affinity Tags  
1.9.1 Significance of affinity tags in purification of recombinant proteins 
Affinity tags are highly efficient and mostly used tools for structural and functional 
proteomics research. They have been developed to facilitate the detection and 
purification of recombinant proteins from cells and in recent years, it has become 
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clear that affinity tags have become indispensable tools for protein studies for 
excellent reasons (Terpe et al. 2003). 
They allow the detection and purification of nearly any protein with hundred or even 
thousand fold purification from crude extracts. There is no need for prior steps to 
remove nucleic acid or other cellular material. Simple experimental procedure and 
mild elution conditions, and for some tag systems, positive impact on the yield, 
solubility and even the folding of their fusion partners, are the strong qualities about 
the tag systems which make them prefferrable over conventional chromatography in 
which highly customized procedures are associated with (Lichty et al. 2005).  
They can be categorized mainly into two classes depending on the nature of the 
affnity tag and its target; First class is the peptide or protein tags which recognize 
small ligands linked to a solid support. The hexahistidine tag and glutathione S-
transferase protein fusions are such tags which bind to immobilized metal and 
glutathione attached to chromatography resin, respectively.  
In the second class, there are peptide tags which bind on a protein binding partner 
immobilized on chromatography resin as the calmodulin-binding peptide tag binds 
specifically to calmodulin allowing proteins fused to the peptide to be purified over 
calmodulin resin. The protein binding partner can also be an antibody, recognizing a 
specific peptide epitope as in the FLAG peptide tag, which can be used with one of 
several anti-FLAG antibody resins.  
1.9.2 Comparison of commercially available peptide/protein tags 
In the last 25 years, a variety of proteins, domains, or peptides have been used as 
affinity tags (reviewed in Nilsson et al. 1997, Heam et al. 2001, Terpe et al. 2003, 
Arnau et al. 2006). For example, a hexahistidine tag (His-tag) (Hochuli et al. 1987, 
Hochuli et al. 1988), glutathione S-transferase and maltose-binding protein (Smith et 
al. 1988, di Guan et al. 1988) and peptide epitopes like the FLAG-tag (Einhauer et 
al. 2001), the calmodulin-binding peptide (Vaillancourt et al. 2000), the Strep-tag or 
Streptag II (Schmidt et al. 1993, Voss et al. 1997) and the biotin acceptor peptide 
(Schatz et al. 1993) were all used as tag system for the purification of proteins form 
cell extract.  
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Figure 1.7: A. Interaction between Ni-NTA and a 6xHis-tagged protein B. 
Purification of 6xHis-tagged proteins (The QIAexpressionist 
Handbook, 2003). 
No single affinity tag is optimal, each one has its weakness and advantages which 
must be considered beforehand. The properties of most of the available affinity tags 
is compared in reviews in which the tags were classified according to cost, yield, 
easiness of experimental procedure (Nilsson et al. 1997, Hearn et al. 2001, Terpe et 
al. 2003, Arnau et al. 2006, Lichty et al. 2005, Waugh et al. 2005). Although they 
have originally been developed to facilitate the detection and purification of 
recombinant proteins, they can also have a positive impact on the yield, solubility 
and even the folding of their fusion partners which are the reasons for preference of 
the tag system over others.  
Table 1.1 is from a review paper (Lichty et al. 2005) comparing the basic tag systems 
in terms of ability to increase the yield, enhance the solubility, and facilitate the 
purification of their fusion partners. 
Peptide epitopes like the FLAG-tag (Nilsson et al. 1997), the calmodulin-binding 
peptide (Hearn et al. 2001), the Strep-tag or Streptag II (Terpe et al. 2003, Arnau et 
al. 2006) and the biotin acceptor peptide (Hochuli et al. 1987) all exhibit a high 
degree of specificity for their cognate binding partners.  
However, the resins (immobilized proteins) that they interact with tend to be 
expensive, are easily fouled and have relatively low binding capacities, making them 
less than ideal for high-throughput applications.  
By contrast, large protein tags usually recognize small ligands that make for less 
expensive and more robust chromatography matrices.  
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Table 1.1 Advantages and disadvantages of some commonly used fusion partners 
[Lichty et al. 2005]. 
 
aGST, glutathione S-transferase; MBP, maltose-binding protein; NusA, N-utilization 
substance A; FLAG, FLAG-tag peptide; BAP, biotin acceptor peptide; His6, hexahistidine 
tag; STREP, streptavidin-binding peptide; SET, solubility-enhancing tag; CBP, calmodulin-
binding peptide. bDerivatives of thioredoxin have been engineered to have affinity for 
immobilized metal ions (His-patch thioredoxin) or avidin/streptavidin. 
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The most popular examples are glutathione S-transferase (GST) (Hochuli et al. 1988) 
and MBP (Smith et al. 1988). One disadvantage of GST is that it is a homodimer (di 
Guan et al. 1988), which can complicate purification of fusion proteins and renders 
this affinity tag unsuitable for the isolation of oligomeric proteins. Moreover, 
whereas MBP contains no cysteine residues, the four solvent exposed cysteines in 
each subunit of the GST dimer can lead to a significant degree of oxidative 
aggregation (di Guan et al. 1988).  
A disadvantage of large protein affinity tags in general is that they devour more 
metabolic energy during overproduction than small tags.  
The hexahistidine tag (His-tag), which binds to immobilized transition metals, is by 
far the most commonly used affinity tag for high-throughput protein purification.  
Virtually all large structural genomics centers use immobilized metal affinity 
chromatography (IMAC) as their principal affinity strategy. Ni(II)-nitrilotriacetic 
acid (Ni-NTA), which exhibits a high affinity for adjacent histidine residues, is the 
most commonly used matrix for IMAC (Einhauer et al. 2001, Vaillancourt et al. 
2000).  
The His-tag combines the advantages of small size with the added benefit of 
interacting with a chromatographic matrix (e.g. Ni-NTA resin) that is relatively 
inexpensive, able to withstand multiple regeneration cycles under stringent sanitizing 
conditions, and exhibits a high binding capacity.  
Moreover, elution conditions are mild and flexible (100–250 mM imidazole, pH!5.0, 
or 10 mM EDTA).  
The His-tag also works well under denaturing conditions, adding yet another 
dimension to its versatility. If a His-tagged recombinant protein is insoluble in E. 
coli, then it can still be purified by IMAC under denaturing conditions and refolded.  
Additionally, because affinity tags have the potential to interfere with structural or 
functional studies, provisions must also be made for removing them. 
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Figure 1.8: A. Interaction between neighboring residues in the 6xHis tag and Ni-
NTA matrix. B. Interactions of metal chelate matrices with nickel ions 
(The QIAexpressionist Handbook, 2003). 
1.10 Expression Systems 
Expression systems can be basically defined into two groups. Cell-based expression 
systems and cell-free expression systems. Cell based systems are the most widely 
used expression systems and they are a combination of  an expression vector, its 
cloned DNA, host cell enabling high level production of foreign protein (Baneyx, 
1999).  
There are many different host cells which may be used for expression. Each one has 
distinct advantages and liabilities. They are normally referred to by the host and the 
DNA source or the delivery mechanism for the genetic material. For example, 
common expression hosts are bacteria (such as E.coli, B.subtilis), yeast (such 
as S.cerevisiae) or eukaryotic cell lines. Common DNA sources and delivery 
mechanisms are viruses (baculovirus, retrovirus, adenovirus etc.), plasmids, artificial 
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chromosomes and bacteriophage (such as lambda phage) (Baneyx, 1999, Cregg et 
al., 2000, Kost et al., 2005). 
Choosing the best expression system depends on the gene involved. For example, 
yeast cells are preferred for proteins that require significant post-translational 
modification, insect or mammal cell lines are used when human-like splicing of the 
mRNA is required. On the other hand, bacterial expression has the advantage of 
easily producing large amounts of protein. 
Cell-free protein expression has been used for several decades for the analysis of 
proteins. The biggest drawback of cell-free systems was usually the low yield of 
target proteins. The widely used E. coli and wheat germ or reticulocyte lysates were 
commercialized by various companies (e.g. Roche, Invitrogen, Qiagen, Novagen) 
indicating that cell-free expression is a valuable method for the analysis of proteins 
(Rosser et al., 2005, Lackner et al., 2008). 
1.10.1 Prokaryotic expression systems 
Prokaryotic recombinant protein expression systems have several advantages 
including ease of culture, and very rapid cell growth. IPTG can be used to easily 
induce bacterial protein expression. Purification is quite simple and there are many 
commercial kits available for recombinant protein expression. 
On the other hand, most proteins become insoluble in inclusion bodies and are very 
difficult to recover as functional proteins (Baneyx, 1999). 
Additionally, most post-translational modifications are not added by bacteria and 
therefore your protein of interest may not be functional.  
1.10.1.1 Eschericia coli  
E. coli is one of the most widely used expression hosts. The overexpression 
techniques in E. coli are well developed and DNA is normally introduced in a 
plasmid expression vector. DNA sequence for a protein of interest could 
be cloned or subcloned into a high copy-number plasmid containing the lac 
promoter, which is then transformed into the bacterium Escherichia coli. Addition 
of IPTG (a lactose analog) activates the lac promoter and causes the bacteria to 
express the protein of interest (Fux et al., 2005, Blattner et al., 1997). 
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1.10.2 Eukaryotic expression systems 
Eukaryotic genes are not really present in prokaryotic cells. E. coli cells frequently 
recognize the protein products of cloned eukaryotic genes as outsiders and destroy 
them. Also, prokaryotes do not carry out the same kinds of posttranslational 
modification as eukaryotes do. Another serious problem is that the interior of a 
bacterial cell is not proper for folding of eukaryotic proteins as the interior of a 
eukaryotic cell resulting improperly folded, inactive products of cloned genes.  
Yeast cells, mammalian cells and insects are available eukaryotic expression 
systems. Advantages of eukaryotic protein expression systems include the fact that 
you can get very high levels of expression. The proteins are easy to purify using 
special tags which are included into the vectors including His, Myc and other tags. 
There will be no inclusion bodies to worry about and proteins will have intact post-
translational modifications. These are vital parameters if the function of the protein 
and/or protein-protein interactions are studied. 
As the disadvantage of using eukaryotic protein expression systems, eukaryotic cells 
grow slower than prokaryotic cells (Cregg et al., 2000, Kost et al., 2005). 
1.10.2.1 Pichia pastoris 
Pichia pastoris is frequently used as an expression system for the production of 
proteins. It has a high growth rate and is able to grow on a simple, inexpensive 
medium. It can grow in either shake flasks or a fermenter, making it suitable for both 
small and large scale production. 
It has two alcohol oxidase genes, AOX1 and AOX2, which have a 
strongly inducible promoter. These genes allow Pichia to use methanol as 
a carbon and energy source. The AOX promoters are induced by methanol and are 
repressed by e.g. glucose.  
The gene for the desired protein is introduced under the control of the AOX1 
promoter so that protein production can be induced by the addition of methanol 
(Cregg et al., 2000).  
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1.11 Functional Proteins 
1.11.1 Recombinant green fluorescent protein (GFPuv)  
1.11.1.1 Green fluorescent protein (GFP) 
Green fluorescent protein (GFP) is a 27-29 kDa protein composed of 238 amino 
acids. It forms an environment for three residues (Ser65–Tyr66–Gly67) to act as a 
fluorophore (Chalfie and Kain, 1998). It has a typical beta barrel structure, consisting 
of one β-sheet with alpha helix(s) containing the chromophore running through the 
center as shown in Figure 1.9. 
 
Figure 1.9: GFP ribbon structure. (Ormö et al., 1996). 
Many marine organisms have green fluorescent proteins but GFP traditionally refers 
to the protein first isolated from the jellyfish Aequorea victoria. The GFP from A. 
victoria has a major excitation peak at 395 nm and a minor one at 475 nm. The 
emission peak is at 509 nm which is in the lower green portion of the visible 
spectrum. 
1.11.1.2 Application areas and GFP derivatives 
GFP gene is frequently used as a reporter of expression (Phillips, 2001). It has been 
introduced and expressed in many bacteria, yeast and other fungi, fish (such 
as zebrafish), plant, fly, and mammalian cells, including human. It has been 
expressed as a proof-of-concept that a gene can be expressed throughout a given 
organism.  
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Many different mutants of GFP have been engineered (Shaner et al., 2005). The 
spectral characteristics of GFP have been improved resulting in increased 
fluorescence, photostability or a shift of the major excitation peak.  
The availability of GFP and its derivatives has thoroughly redefined fluorescence 
microscopy and the way it is used in cell biology and other biological disciplines 
(Yuste, 2005). Most small fluorescent molecules such as FITC (fluorescein 
isothiocyanate) are strongly phototoxic when used in living cells but fluorescent 
proteins such as GFP are usually much less harmful when illuminated in living cells. 
In cells where the gene is expressed, and the tagged proteins are produced, GFP is 
produced at the same time. Thus, only those cells in which the tagged gene is 
expressed, or the target proteins are produced, will fluoresce when observed under 
fluorescence microscopy. Through its ability to form internal chromophore without 
requiring accessory cofactors, enzymes or substrates other than molecular oxygen, 
GFP makes for an excellent tool in all forms of biology (Stepanenko et al., 2008).  
1.11.1.3 Recombinant green fluorescent protein-GFPuv 
GFPuv was developed by introducing point mutations that replaced three amino acid 
codons in the native GFP DNA sequence (Chalfie et al., 1994, Crameri et al., 1996). 
It has been shown to be resistant to heat (T > 70°C) and alkaline pH (between 5.5 and 
12.0; optimum = 8.0). 
GFPuv is expressed two to three times faster in E. coli and exhibits eighteen-fold 
greater fluorescence intensity than native GFP. With the excitation/emission maxima 
of 395/509 nm (Chalfie and Kain, 1998, Chalfie et al., 1994), the fluorescence 
characteristics of GFPuv can be quantified for in vivo and in vitro studies by a variety 
of techniques using fluorescence microscopy, flow cytometry and 
spectrofluorometry. 
1.11.2 Alkaline phosphatase  
1.11.2.1 Characteristics 
Alkaline phosphatase (AP, EC 3.1.3.1) is a dimer hydrolase enzyme. It is a dimer 
(MW = 140.000) of identical or nearly identical sub-units (MW = 69,000). 
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Each momoner contains 2 molecules of Zn2+, one tightly bound and necessary for 
structural stability, the other loosely bound and required for catalytic activity. There 
is a reactive serine in active site.  
 
Figure 1.10: Cartoon diagram (rainblow colored, N-terminus = blue, C-terminus = 
red]) of the dimeric structure of bacterial alkaline phosphatase based on 
the PDB 1ALK coordinates (Kim et al., 1991). 
 
Alkaline phosphatase (AP) hydrolyzes phosphate esters of primary and secondary 
alcohols, cyclic aliphatic alcohols, sugar alcohols, phenols, and amines. AP also 
hydrolyzes inorganic pyrophosphate (at a pH optimum of approx. 8) and 5'-terminal 
phosphates of single and double-stranded DNA or RNA (Kim et al., 1991).  
1.11.2.2 Application areas 
It has become a useful tool in molecular biology laboratories. It has been widely used 
in immunoassays for removing inorganic phosphate groups from various types of 
molecules such as proteins and DNA (Anderson et al., 1975).  
DNA possesses phosphate groups on the 5' end. Removing these phosphates prevents 
the DNA from ligating, thereby keeping DNA molecules linear until the next step of 
the process for which they are being prepared; also, removal of the phosphate groups 
allows radiolabeling (replacement by radioactive phosphate groups) in order to 
measure the presence of the labeled DNA through further steps in the process or 
experiment.  
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Another important use of alkaline phosphatase is as a label for enzyme 
immunoassays.  
The wide utility of AP in biochemical, immunological, and medical assays resulted 
in numerous studies investigating the immobilization of AP via fusion peptides on 
solid supports (Brennann et al., 1995, Tominaga et al., 2005, Zhang et al., 2001). 
1.11.3 Laccases  
1.11.3.1 Characteristics 
Laccases (benzenediol:oxygen oxidoreductases, EC 1.10. 3.2) are the largest 
subgroup of blue multicopper oxidases (MCO). They contain copper atoms in the 
catalytic centre which gives their redox ability to catalyze the oxidation of a wide 
range of aromatic substrates simultaneously with the reduction of molecular oxygen 
to water (Solomon et al., 1996).  
 
Figure 1.11: Laccase from T. Versicolor. 
Laccases have been found in nearly all woodrotting fungi (Heinzkill et al., 1997) and 
isolated from plants, from some kinds of bacteria, and from insects too (Bao et al., 
1993, Sato et al., 2001, Sharma et al., 2007, Roberts et al., 2002). In fungi, laccases 
carry out a variety of physiological roles including morphogenesis, fungal plant 
pathogen/host interaction, stress defense, and lignin degradation (Thurston et al., 
1994, Ginfreda et al., 1999). In plants, laccases have been found in the wood and 
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cellular walls of herbaceous species (Bao et al., 1993), and participate in the radical-
based mechanisms of lignin polymer formation (Sterjiades et al., 1992; Liu et al., 
1994; Boudet, 2000; Ranocha et al., 2002; Hoopes & Dean, 2004). In bacteria, 
laccases  have a role in morphogenesis, in the biosynthesis of the brown spore 
pigment and in the protection afforded by the spore coat against UV light and 
hydrogen peroxide, and in copper homeostasis. In insects, laccase-type proteins is 
believed to affect the sclerotization of the cuticle in the epidermis. 
The physiological function of laccase in the organism usually determines the 
localization of the enzyme in the cell. Because of lignin degradation process, most 
laccases are extracellular enzymes. On the other hand, the laccases of wood-rotting 
fungi are also found intracellularly. Periplasmic laccases in bacterial cells could play 
role in the transformation of low molecular weight phenolic compounds in the cell. 
(Eggert et al., 1995; Galhaup & Haltrich, 2001). 
The majority of the fungal laccases are monomeric globular proteins of 
approximately 60–70 kDa.They are generally glycosylated and acidic isoelectric 
point (pI) is around pH 4.0. Laccases contain three types of copper. One of these 
coppers gives lacccase its characteristic blue colour.  
Laccases catalyze the reduction of oxygen to water accompanied by the oxidation of 
a substrate (as hydrogen donors) such as ortho and para-diphenols, aminophenols, 
polyphenols, polyamines, and aryl diamines as well as some inorganic ions. 
Commonly used phenolic substrates for laccases are syringaldazine, DMP and 
guaiacol. On the other hand, they are also able to oxidize electron donor substrates 
such as ABTS [2,20-azino-bis(3- ethylbenzothiazoline-6-sulfonic acid)].  
1.11.3.2 Application areas 
Because of their high nonspecific oxidation capacity, and because they use readily 
available molecular oxygen as an electron acceptor, laccases are useful biocatalysts 
for a wide range of biotechnological applications. They do not need the addition or 
synthesis of a low molecular weight cofactor like hydrogen peroxide, as its 
cosubstrate – oxygen – is usually present in its environment. Most laccases are 
extracellular enzymes, making the purification procedures very easy. They generally 
exhibit a considerable level of stability in the extracellular environment.  
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There are many potential application areas for lacceases such as in pulp 
delignification and biobleaching (Bajpai et al., 1999), treatment of industrial plant 
wastewater (Dura´n et al., 2000) , enzymatic modification of fibers and dye-
bleaching in the textile and dye industries (Abadulla et al., 2000), enzymatic removal 
of phenolic compounds in beverages, fruit juice processing (Minussi et al., 2002), 
and biosensor and biofuel cell construction (Amir et al., 2009). 
1.12. Aim of the Study 
We used one of the Quartz Binding Peptides, QBP-1 (PPPWLPYMPPWS), which 
was developed using computational tools based on the knowledge generated through 
phage display technology. The selected peptide’s ability to bind strongly and 
specifically on silica material makes it a strong candidate to form a novel tag system 
for protein purification purposes. 
Firstly, prokaryotic expression systems were used for the formation of QBP1-
functional protein fusion proteins. Alkaline phosphatase and recombinant GFP 
proteins were tagged with QBP1 peptide at the DNA level and optimization of 
protein expressin was performed.  
Secondly, eukaryotic expression systems were used for protein expression and then 
purification purpose. QBP1 peptide was placed at the N terminus of the laccase 
enzyme (lcc1) in Pichia pastoris yeast cells to form a hybrid fusion molecule. After 
the optimization of protein expression, QBP1 peptide was used as tag molecule to 
purify the tagged protein form cell extract using silica/quartz columns.  
Here, we show that combinatorially selected and then bioinformatically enhanced 
quartz binding peptides can be used as a tag molecule for prokaryotic and eukaryotic 
protein expression purposes. 
The tag molecule does not have a significant effect on the activity of the main protein 
and also, it does not affect the esecretion of the tagged protein out of the cell. Finally, 
QBP1 peptide is used as a “TAG” molecule for purification of fusion molecule 
through silica/ quartz packed columns. 
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2.  MATERIALS AND METHODS 
2.1. Materials 
2.1.1. Bacterial and yeast strains 
2.1.1.1. E. coli DH5αTM-T1R host strain 
F
-
 φ80lacZΔM15 Δ(lacZYA-argF) U169 deoR recA1 endA1 hsdR17 (rk-, mk+) phoA 
supE44 λ- thi-1 gyrA96 relA1 tonA, chemically competent cells were  supplied with 
Gene-TailorTM Site-Directed Mutagenesis System (Catalog#12297-016, Invitrogen). 
2.1.1.2. E. coli TunerTM(DE3)pLacI host strain 
F
- 
ompT hsdSB (rB
- 
mB
-
) gal dcm lacY1 (DE3) pLacI (CmR), chemically competent 
cells compatible with expression from pETBlueTM vectors, were supplied with 
pETBlue™ System (Catalog#70674-3, Novagen).  
2.1.1.3 E. coli One Shot® TOP10 host strain 
F
-
 mcrA ∆(mrr-hsdRMS-mcrBC) φ80lacZ∆M15 ∆lacX74 recA1 araD139 ∆(ara-
leu)7697 galU galK rpsL (StrR) endA1 nupG, electrocompetent and chemically 
competent cells were supplied with One Shot® TOP10 Competent Cells (Catalog# 
C4040-52, Invitrogen)  
2.1.1.4 E. coli BL21(DE3) host strain 
B F
–
dcm ompT hsdS(rB
– 
mB
–) gal λ(DE3)BL21(DE3) strain electrocompetent and 
chemically competent cells were supplied with (Catalog #C6000-03 Invitrogen) 
2.1.1.5 Pichia pastoris host strain 
Yeast host strain was a commonly used strain of Pichia pastoris which was supplied 
in “EasySelect™ Pichia Expression Kit, For Expression of Recombinant Proteins 
Using pPICZ and pPICZα in Pichia pastoris” kit from Invitrogen. (Cat. no. K1740-
0) 
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2.1.2. Inorganic targets: quartz and silica beads  
Quartz and silica powders were obtained from Merck Company (ABD). Silica gel 
was 0,063-0,200 mm in diameter (Lot no: 1.07734.1000), quartz was 0,2-0,8 mm in 
diameter (1.07536.1000).  
2.1.3. Bacterial culture media 
2.1.3.1. Luria Bertani (LB) medium 
10 g tryptone (Acumedia), 5 g yeast extract (Acumedia), 5 g NaCl (Riedel-de-Haen) 
were dissolved in distilled water and completed up to 1 lt and the pH was adjusted to 
7.0-7.5 with 10 M NaOH and sterilized for 15 min. under 1.5 atm at 121 ˚C. The 
medium was stored at room temperature. 
2.1.3.2. LB agar medium 
10 g tryptone (Acumedia), 5 g yeast extract (Acumedia), 5g NaCl (Riedel-de-Haen), 
15 g bactoagar (Acumedia) were dissolved in distilled water and completed up to 1lt 
and the pH was adjusted to 7.0-7.5 with 10 M NaOH and sterilized for 15 minutes 
under 1.5 atm at 121˚C. Following autoclaving, tetracycline solution (Sigma) (final 
concentration of 10 μg/ml) and X-gal/IPTG solution (final concentration of 40 
μg/ml) (Fermentas/Sigma) were added when the temperature of the medium was 
cooled down to 45-50 ºC. The medium was shaken properly and poured into the 
plates by avoiding any bubble formation (3.5 ml for small plates and 15 ml for big 
plates). After the medium was solidified in the plates, they were turned upside down 
and stored at 4 ˚C for later use. 
2.1.3.3. 2xYT medium 
16 g tryptone (Acumedia), 10 g yeast extract (Acumedia), 5g NaCl (Riedel-de-Haen) 
were dissolved in distilled water and completed up to 1lt and the pH was adjusted to 
7.0 with 10 M NaOH and sterilized for 15 minutes under 1.5 atm at 121˚C. per liter. 
The medium was stored at room temperature. 
2.1.3.4. MagicMedia E.coli expression medium 
MagicMedia™ E. coli Expression Medium is specifically designed to dramatically 
increase the yield of recombinant proteins in T7-regulated E. coli expression systems 
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without monitoring culture O.D. (optical densities) or adding inducer. The 
proprietary MagicMedia™ formulation enables E. coli growth to reach culture 
densities 3-10-fold higher than those achieved with traditional LB + IPTG methods. 
The medium was supplied in “MagicMedia™ E. coli Expression Medium 
SoluPouch™” kit from Invitrogen. (Cat. no. K6802) 
 2.1.3.5. SOC medium 
20 g tryptone, 5 g yeast extract, 0.5 g NaCl was dissolved in 950 mL deionized 
water. 10 mL of 250 mM KCl was added and pH was adjusted to 7.0 with NaOH. 
Water was added up to 1lt and sterilized by autoclaving. Just before use, 10mM of 
MgCl2 and 20mM of glucose were added.  
2.1.3.6. E. coli overnight culture 
5 ml LB solution containing 1 mM MgCl2 and tetracycline, was inoculated with E. 
coli ER-2738 stock (from -80°C). The culture was left in the shaker overnight at 
37°C, 200 rpm.  
2.1.4. Yeast culture media 
2.1.4.1. Minimal methanol medium   
13.4 g of yeast nitrogen base with ammonium sulfate and without amino acids was 
dissolved in 993 ml of water, 15 g of agar was added and sterilized for 15 minutes on 
liquid  cycle.  5  ml  of  methanol  and  2  ml  of  filter-sterilized  500x  biotin  were  
added. (1.34 % YNB, 4 x 10
–5
 % Biotin and 0.5 % Methanol). Medium was cooled to 
~60°C and poured.  
2.1.4.2. Buffered minimal  glycerol and buffered minimal methanol media,  
BMG and  BMM    
13.4  g  of  yeast  nitrogen  base  with  ammonium  sulfate  and  without  amino  
acids  was dissolved  in  890  ml  of  distilled  water  and  sterilized  for  15  minutes  
on  liquid  cycle. Following to cooling the medium to ~60°C, 100 ml of pre-sterilized 
1 M potassium phosphate buffer, pH 6.0, 2 ml of filter-sterilized 500x biotin and 10 
ml of glycerol was added. 5 ml of methanol was added for BMM instead of glycerol. 
(100 mM potassium phosphate buffer,  pH 6.0, 1.34 % YNB, 4 x 10
–5
 % Biotin and 
0.5 % Methanol or 1 % Glycerol)          
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2.1.4.3. Buffered glycerol-complex medium, BMGY and BMMY   
10 g of yeast extract, 20 g of mycological peptone and 13.4 g of yeast nitrogen base 
with ammonium sulfate and without amino acids was dissolved in 890 ml of distilled 
water and sterilized for 15 minutes on liquid cycle. Following to cooling the medium 
to ~60°C, 100 ml of pre-sterilized 1 M potassium phosphate buffer, pH 6.0, 2 ml of 
filter-sterilized 500x biotin and 10 ml of glycerol was added. 5 ml of methanol was 
added for BMMY instead of glycerol. (100 mM potassium phosphate buffer,  pH 6.0, 
1.34 % YNB, 1 % Yeast Extract, 4 x 10
–5
 % Biotin, 2 % Mycological peptone and 
0.5 % Methanol or 1 % Glycerol) 
2.1.5. Stock solutions 
2.1.5.1. Tetracyline-HCl stock solution 
20 mg/ml tetracycline-HCl (Sigma) was dissolved in distilled water. It was then 
stored at -20°C at dark to protect from the light. Tetracycline is light-sensitive.  
2.1.5.2. Ampicillin stock solution 
1g ampicillin sodium salt (Fisher BP1760-25) was dissolved in 10 ml distilled water 
(100 mg/ml) and filter sterilized using 0.22µm syringe filter. It was then stored at -
20°C.     
2.1.5.3. Kanamycin stock solution 
1 g kanamycin sulfate was dissolve in 35 ml of distilled water and the volume was 
made up to 40 ml with distilled water (25 mg/ml) and filter sterilized using 0.22µm 
syringe filter. It was then stored at -20°C.     
2.1.5.4. Chloramphenicol stock 
34 mg/mL chloramphenicol was dissolved in 100% ethanol, filter-sterilized and 
stored at -20°C.  
2.1.5.5. Zeocin stock solution 
1g zeocin was dissolved in 10 ml distilled water (100 mg/ml) and filter sterilized 
using 0.22µm syringe filter. It was then stored at -20°C.     
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2.1.5.6. Xgal/ IPTG stock 
1.25 g IPTG (isopropyl β-D-thiogalactoside) (Sigma) and 1 g Xgal (5-Bromo-4-
chloro-3 indolyl-β-D-galactoside) (Fermentas) were dissolved in 25 ml Dimethyl 
formamide (Riedel-de-Haen). Solution was stored at –20°C at dark to protect from 
the light. 
2.1.5.7. Detergent stock  
20 % (w/v) Tween 20 (Riedel-de-Haen) and 20 % (w/v) Tween 80 (Merck) were 
mixed and distilled water was added up to 20 ml.  
2.1.5.8. Glycerol stock solution   
50 ml of 100% glycerol (Sigma) was mixed with distilled water up to 100 ml total 
volume to have 50 % glycerol solution. It was sterilized for 15 minutes under 1.5 atm 
at 121˚C and then stored at room temperature.  
2.1.5.9. MgCl2 stock solution 
1M  MgCl2.6H2O (Fisher) was dissolved in distilled water up to 100 ml. and 
sterilized with 0.2 μm single use syringe filter.         
2.1.6 Buffer solutions 
2.1.6.1. Phage display buffers 
 PC  (Potassium Phosphate-Sodium Carbonate Buffer) (no detergent): 55 
mM KH2PO4 (Fisher), 45 mM Na2CO3 (Fisher), 200 mM NaCl (Sigma) were 
dissolved in distilled water up to 500 ml and the solution was sterilized by using 0.2 
μm single use syringe filter. The pH value was adjusted to 7.2-7.5.                       
 PC (containing 0.02% detergent): 55 mM KH2PO4 (Fisher), 45 mM 
Na2CO3 (Fisher), 200 mM NaCl (Sigma), 0.5 ml detergent stock solution were 
dissolved in distilled water up to 500 ml and the solution was sterilized by using 0.2 
μm single use syringe filter. The pH value was adjusted to 7.2-7.5.   
 PC (containing 0.1% detergent): 55 mM KH2PO4 (Fisher), 45 mM Na2CO3 
(Fisher), 200 mM NaCl (Sigma), 2.5 ml detergent stock solution were dissolved in 
distilled water up to 500 ml. and the solution was sterilized by using 0.2 μm single 
use syringe filter. The pH value was adjusted to 7.2-7.5.   
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 PC (containing 0.5% detergent): 55 mM KH2PO4 (Fisher), 45 mM Na2CO3 
(Fisher), 200 mM NaCl (Sigma), 12.5 ml detergent stock solution were dissolved in 
distilled water up to 500 ml. and the solution was sterilized by using 0.2 μm single 
use syringe filter. The pH value was adjusted to 7.2-7.5.  
Note: PC buffer can not be sterilized because carbonate ions convert to C02 due to 
high pressure in the autoclave. This causes an increasing of pH up to 10. 
 Elution buffer: 0.2 M glycine (Merck) and 1mg /ml BSA (Sigma) were 
dissolved in distilled water up to 50 ml. and pH was adjusted to 2.2 with 10 M HCl 
and 0,1M HCl. The solution was sterilized by using 0.2 μm single use syringe filter. 
 Tris Buffer: 5% casein (Sigma), 10 mM Tris-base (Merck), 150 mM NaCl, 
1% tween 20 (Riedel-de-Haen) was dissolved in 0.1 M NaOH. pH was adjusted to 
8.2 and distilled water was added up to 50 ml. 
2.1.6.2. Electrophoresis buffers 
Agarose gel electrophoresis, SDS-PAGE and native-PAGE buffers are given in 
Section 2.2 
2.1.6.3. Sil-TAG application buffers 
 Binding Buffer: PC buffer (pH.7,5) containing 0% detergent was used as 
binding buffer.  
 Washing Buffer: Different concentrations and pH values of PC buffer 
(pH.6,5-7,5 + 0-0.5%Tween20) were used as washing buffers. 
 Elution Buffers: Different concentrations and pH values of PC buffer (pH.3-
7,5 ± 0-5%Tween20 ± 2M MgCl2 ± 1M Imidazole) were used as elution buffers. 
2.1.7. DNA and protein molecular weight markers  
DNA molecular weight standard markers (See Appendix C) were obtained from MBI 
Fermentas.  
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2.1.8. Oligonucleotides 
Oligonucleotides given in Appendix B were synthesised by Alpha DNA on 
automated computer-controlled synthesizers using standard phosphoramidite 
chemistry. The oligonucleotides were purchased as lyophilized form. 
2.1.9. Cloning and expression vectors 
All the cloning and expression vectors were given in Appendix B. 
2.1.9.1. pCR®2.1-TOPO® cloning vector 
pCR®2.1-TOPO® cloning vector (See Appendix-A) was purchased from 
Invitrogen
TM
 (Catalog#K4560-40) to be used for cloning of PCR products containing 
the single A (Adenine) overhang at each end. Adenine nucleotide was added at 3’ 
ends of blunt-ended PCR products using QIAGEN A-Addition Kit (Catalog# 
231994, Qiagen). 
2.1.9.2. pGEM®-T and pGEM®-T easy vector systems 
The pGEM
®
-T and pGEM
®
-T Easy Vector Systems are convenient systems for the 
cloning of PCR products which were purchased from Promega and supplied in a kit 
including a 2X Rapid Ligation Buffer for ligation of PCR products. (Catalog# 
A1360, Promega) 
2.1.9.3. pPICZ-B expression vector  
pPICZ-B expression vector (See Appendix-A) was purchased from Invitrogen
TM
 
(Catalog#V190-20). It is 3.3 kb expression vector used to express recombinant 
proteins in Pichia pastoris. The vector allows high-level, methanol inducible 
expression of the gene of interest in Pichia, and can be used in any Pichia strain 
including X33, GS115, SMD1168H, and KM71H.  
2.1.9.4. pETBlue-2 expression vector 
The pETBlue™ vectors are designed to identify recombinants by traditional 
blue/white screening while also allowing T7lac promoter based expression of target 
genes. pETBlue-2 vector (See Appendix A) was purchased from Novagen 
(Catalog#70674-3, EMD Biosciences, Inc.). 
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2.1.9.5. pQE-60 expression vector 
pQE-60 Expression Vector is designed for high-level expression of 6xHis-tagged 
proteins in E. coli, based on the T5 promoter transcription–translation system. (See 
Appendix A) It was purchased from Qiagen (Catalog#32903). 
2.1.10. Enzymes 
2.1.10.1. Restriction enzymes  
EcoRI (G^AATTC, Fermentas), PstI (CTGCA^G, Fermentas), BglII (A^GATCT, 
Fermentas) and NcoI (C^CATGG, Fermentas) restriction endonucleases and their 
reaction buffers were obtained from Fermentas (Catalog #ER0611, ER0081). 
2.1.10.2. Taq DNA polymerase  
The Taq DNA Polymerase is a highly thermostable DNA polymerase that catalyzes 
template-dependent polymerization of nucleotides into duplex DNA in the 5'=>3' 
direction. The Taq DNA Polymerase possesses low 5'=>3' exonuclease activity and 
has no detectable 3'=>5' exonuclease (proofreading) activity. Like other DNA 
polymerases without 3'=>5' exonuclease activity, Taq DNA Polymerase exhibits 
deoxynucleotidyl transferase activity, which frequently results in the addition of 
extra adenines at the 3'-end of PCR products (Catalog # EP0402, Fermentas). 
2.1.10.3. Pfu DNA polymerase 
The Pfu DNA Polymerase is a highly thermostable DNA polymerase that catalyzes 
the template-dependent polymerization of nucleotides into duplex DNA in the 5'=>3' 
direction. The Pfu DNA Polymerase also exhibits 3'=>5' exonuclease (proofreading) 
activity, that enables the polymerase to correct nucleotide incorporation errors. The 
enzyme has no 5'=>3' exonuclease activity (Catalog#EP0502, Fermentas). 
2.1.10.4. Quick T4 DNA ligase 
Quick T4 DNA ligase was supplied with Quick Ligation
TM
 Kit purchased from New 
England Biolabs, Inc (Catalog # M2200S). 
2.1.11. Lab equipment 
Autoclave : Yamato sterilizer SE 510. 
Balances : Denver Toledo AB 54 
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Centrifuge :Sorvall RC 5B Plus Kendro Laboratory 
Products  Eppendorf Centrifuge 5415D 
Centrifuge rotors : SA-600, SLA-1500, SH-3000, PN-11779. 
Deep freezes and refrigerators : Heto Polar Bear 4410 ultra freezer, JOUAN 
Nordic  A/S,  catalog# 003431.  
Deionized water : Millipore Milli Q Synthesis A 10  
Electrophoresis equipments  : E-C Mini Cell Primo EC320, E-C Apparatus. 
: Mini-PROTEAN 3 Cell and Single-Row 
AnyGel Stand, Catalog# 165-3321,Bio-Rad. 
: Mini-V 8.10 Vertical Gel Electrophoresis 
System, Life Technologies GibcoBrl (now 
Invitrogen), Catalog# 21078. 
Gel documentation system   : UVIpro GAS7000, UVItec Limited. 
Glassware : Technische Glaswerke Ilmenau GmbH. 
Ice Machine : Cornelius Ice Systems 
Incubators : Quincy Lab. Inc. Model 10-14 Incubator 
VWR 1310  
Laminar Flow Cabinet : Airclean 600 PCR Workstation ISC 
Bioexpress 
Orbital shaker : Innova 3100 Water Bath Shaker New 
Brunswick  Scientific 
Magnetic stirrer : AGE 10.0164, VELP Scientifica srl.: ARE 
10.0162,  VELP Scientifica srl. 
Pipettes : Pipetteman 1-20-200-1000-5000 ml 
pH meter : MP 220, Mettler Toledo International Inc.: 
Inolab pH  level 1, order# 1A10-1113,Wissenschaftlich-
Technische  Werkstätten GmbH & Co KG.  
PCR cycler : Eppendorf Master Cycler Gradient  
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Power supply : EC 250-90, E-C Apparatus 
Sequencer : Applied Biosystems 3730XL 
Spectrophotometer : Tecan Safire  
     : DU530 Life Science UV/ Vis, Beckman. 
: UV-1601, Shimadzu Corporation. 
 
Sterilizer : FN 500, Nuve. 
Ultrasonic bath : Branson 1200 
Vortexing machine   : Reax Top, product# 541-10000, Heidolph2.2. 
 
2.2 Methods  
2.2.1 Identification of silica-binding peptides 
The quartz-binding peptide-QBP-1 (PPPWLPYMPPWS) has been obtained by 
previous experiments in our group as followed; firstly, quartz binding peptides have 
been selected by Phage Display Methodology and the selected peptides were 
characterized and grouped using Fluorescence Microscopy, Similarity Analysis and 
Biomineralization Experiments. Peptides were produced using phage-display 
qtechniques as described in Naik et al. (2002), Sarikaya et al. (2003), Smith (1985) 
and Whaley et al. (2001).  
2.2.2 Enhancement of binders by bioinformatic techniques  
The properties of the experimentally selected binders have been used to generate De 
novo binders using bioinformatics tools, naming the best De novo binder as QBP-
1.To accomplish this, we first generated random sequences based on the observed 
amino acid frequencies in the phage library used for the combinatorial selection. We 
then calculated the TSS between each of these sequences and the experimentally 
determined strong binder group. Sequences with the highest and lowest similarity 
scores were considered to represent the strongest and weakest binders, respectively. 
QBP1 sequence is formed as the best silica binder according to the details of 
enhancement procedure, which are given elsewhere (Oren et al. 2007). 
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2.2.3. DNA based studies 
2.2.3.1 QBP1 oligo construction and cloning 
The designed 143 bp long ssDNA (Figure 3.1) (QBP1+14 aa linker+enzyme cutting 
sites) was synthesized commercially (Alpha DNA/Quebec/Canada). The designed 
single strand QBP-1 oligo was PCR amplified and cloned into pGEM-T vector for 
practical uses.  
Synthesis of double stranded QBP-1 oligonucleotide: Optimized PCR conditions 
to make dsDNA oligo was as followed: Initial denaturation at 95
o
C for 4 min, 
denaturation at 95
 o
C for 1 min, annealing at 60 
o
C for 1 min, extension at 72
 o
C for 1 
min and final elongation at 72
 o
C for 5 min. 30 cycles of reaction was performed 
using Taq and Pfu polymerases (Fermentas). 
Polymerase chain reaction (PCR) was obtained with forward and reverse primers in 
order to obtain double-stranded DNA from the synthesized oligonucleotide. Reaction 
conditions are described below: 
Table 2.1: Polymerase Chain Reaction (PCR) ingredients and reaction conditions. 
Ingredients Volume/Concentration Reaction Steps Temp. Time 
Template DNA 0.5 µl (10 pmol) Initial Denaturation  95°C   4 min 
Forward Primer 1 µl (10 pmol) Denaturation 94°C 1 min 
Reverse Primer 1 µl (10 pmol) Annealing 60°C   1 min 
dNTP 2 µl (10mM each) Extension 72°C 1 min 
Taq Buffer 5 µl (10X) No. of Cycles 30   
Taq/Pfu 
polymerase 0.5 µl Final Elongation  72°C 5 min 
dH2O 40 µl 
   Total Volume 50 µl 
   
PCR product was run on 2.5% agarose gel and desired gene product was extracted 
from the gel.     
Agarose gel electrophoresis of PCR products: After the amplification of the oligo, 
PCR products were analyzed on agarose gel electrophoresis. Firstly, for %1 gel, 0.5 
gr agarose was added in 50 ml 0.5X TAE buffer and then gel solution was boiled in a 
microwave until the agarose was completely dissolved. After cooling the solution to 
about 60°C, ethidium bromide was added to the gel solution to a final concentration 
of 0.5 ug/ml. 
Then, gel solution was poured into gel casting tray and a proper comb was placed in 
gel tray. After the gel had been solidified, the comb was removed and gel was placed 
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in electrophoresis chamber containing the appropriate amount of 0.5X TBE buffer. 
An appropriate molecular weight marker (Marker 9, Fermentas) and PCR product 
samples that were mixed with the 6X loading dye depending on volume were pipeted 
into the gel wells. Gel was run at 80 V for 20 min. EtBr-stained DNA bands were 
visualized by UV trans-illuminator. 
TBE (Tris / Borate / EDTA) solution: 10X TBE buffer was prepared by dissolving 
108 g tris-base (Merck), 55 g boric acid (Riedel-de-Haen.) and 4 % (v/v) 0.5M 
EDTA (Merck) pH 8.0. Distilled water was added to complete up to 1 l. 
Gel extraction procedure: Gel extraction reactions in this study are performed by 
MinElute Gel Extraction Kit (Catalog # 28604, Qiagen).  
1. DNA fragment was excised from agarose gel with a clean scalpel. Gel slices 
were put into microfuge tubes and their weight was calculated.  
2. A 3-gel volume of QG buffer was added to 1 volume of gel slice. (600 µl for 
100 mg gel). When gels were excised from a %2 or more concentrated gel, a 
6-gel volume of QG buffer was applied.  
3. Sample was incubated at 50oC for 10 min. by vortexing every 2 min. 
4. After the gel completely dissolved, the color of the mixture was checked. QG 
buffer contains a pH indicator and gives a yellow color at pH<7.5, the 
optimum pH for DNA adsorption. If the color of the mixture was not yellow, 
10 µl of 3 M sodium acetate, pH5.0 was added. 
5. After the gel dissolved, 1 gel volume of room temperature 100% isoproponal 
was added and mixed by inverting the tube several times. 
6. Sample was applied to the MinElute column and centrifuged for 1 min. at 
13000 rpm. 
7. Flow-trough was discarded from collection tube. 
8. 500 µl QG buffer was applied to column and centrifuged for 1 min. at 13000 
rpm. 
9. Flow-trough was discarded from collection tube. 
10. In order to wash, 750 µl PE buffer was applied to the column and centrifuged 
for 1 min. at 13000 rpm. 
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11. Flow-through was discarded from collection tube and centrifuged for an 
additional 1 min. 
12. Spin column was placed in a microfuge and 10 µl EB buffer was applied to 
elute the DNA. After 1 min. incubation the tube was centrifuged for 1 min. 
Eluted DNA is stored at –4oC prior to usage 
Cloning of QBP-1 oligo into a TA vector: QBP-1 oligo was then ligated into 
pGEM-T cloning vector by using Promega pGEM-T vector system and Qiagen 
Quick Ligation™ Kit. Ligation reactions was set up as following; 5μl of 2X Rapid 
Ligation Buffer, 1μl of pGEM®-T (50ng), 2μl of PCR product (8ng), 1μl of T4 DNA 
Ligase (3 Weiss units/μl) and deionized water to a final volume of 10μl. The 
reactions was mized by pipetting and incubated for 1 hour at room temperature. 
 
Table 2.2: Ligation reaction, performed according to Promega pGEM-T vector 
system and Qiagen Quick Ligation™ Kit. 
 
  
Ligation reaction was also performed according to TOPO TA Cloning
®
 Kit (Catalog 
# K 4500-01, Invitrogen) into pCR2.1-TOPO TA Cloning Vector. 
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Table 2.3: Ligation reaction, performed according to TOPO TA Cloning
®
 Kit. 
 
The reaction was mixed gently and incubated for 15 minutes at room temperature 
(22-23°C). The reaction was placed on ice and proceeded to transformation. 
Chemical transformation procedure: 2 µl of the cloning reaction was added into a 
vial of One Shot DH5α-T1 chemically competent E. coli and/or a sterile 1.5ml 
microcentrifuge tube on ice containing 50μl of thawed JM109 High Efficiency 
Competent Cells. 
The samples were incubated on ice for 15 minutes. Heat-shock was applied to the 
cells for 30 seconds at 42°C without shaking. The tubes were transferred 
immediately to ice.  250 µl of room temperature S.O.C. medium was added. The tube 
was capped tightly and shaken horizontally (200 rpm) at 37°C for 1 hour.  
Plating and colony selection: 100 µl of transformation culture is plated onto the LB 
Agar plates (100μg/ml Amp + Xgal-IPTG) for overnight incubation at 37 ºC. White 
colonies are picked from the plate with a pipette tip  5 ml LB Medium with the 
pipette tip was inoculated Incubation for 4.5 hours at 37 ºC (OD600 : 1.5-5) After 
incubation, 2 ml of culture is mixed with glycerol (15%) and vortexed to keep at -80 
ºC. 
Plasmid purification: White colonies obtained subsequent to transformation were 
selected and incubated overnight in 5 mL LB containing 100 µg/mL ampicillin. 700 
l of this bacterial culture was mixed with 300 l 50% glycerol and stored at –80oC. 
Plasmid DNA was purified from 4 mL bacterial culture for sequencing and further 
applications by High Pure Plasmid Isolation Kit (Catalog # 11 754 785 001, Roche). 
Procedure is described in detail below. 
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1. 4 mL bacterial culture was divided into two 2 mL microfuge tubes and 
centrifuged in a standard bench-top microcentrifuge at 6 000 x g for 1 minute. 
The supernatant was discarded. 
2. 250 µl Suspension Buffer containing RNase was added to each microfuge 
tube containing the bacterial pellet. The bacterial pellet was resuspended and 
mixed well. 
3. 250 µl Lysis Buffer was added to the resuspended bacterial pellet and mixed 
gently by inverting the tube 3 to 6 times. The tube was incubated for 5 min at 
room temperature (25°C). 
4. 350 µl chilled Binding Buffer was added to the lysed solution and mixed 
gently by inverting the tube 3 to 6 times. Incubated on ice for 5 min. 
5. Centrifuged for 10 min at approximately 13 000 x g (full speed) in a standard 
tabletop microcentrifuge. 
6. After centrifugation one High Pure Filter Tube was inserted into one 
Collection Tube. The entire entire supernatant from Step 5 was transferred 
into upper buffer reservoir of the Filter Tube. The entire High Pure Tube 
assembly was inserted into a standard tabletop microcentrifuge and 
centrifuged for 1 min at 13 000 x g. 
7. After centrifugation the Filter Tube was removed from the Collection Tube, 
the flowthrough liquid was discarded, and the Filter Tube was reinserted in 
the same Collection Tube. 
8. To wash the cells 700 µl Wash Buffer II was added to the upper reservoir of 
the Filter Tube and centrifuged for 1 min at 13 000 x g in a standard tabletop 
microcentrifuge. 
9. After discarding the flowthrough liquid the entire High Pure Tube assembly 
was centrifuged for an additional 1 min to remove residual Wash Buffer. The 
collection tube was discarded. 
10. To elute the DNA the Filter Tube was inserted into a clean, sterile 1.5 ml 
microcentrifuge tube. 100 µl Elution Buffer or double distilled water (pH 
adjusted to 8.0 – 8.5) was added to the upper reservoir of the Filter Tube. The 
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tube assembly was centrifuged for 1 min at 13 000 x g in a standard tabletop 
microcentrifuge. 
11. The microcentrifuge tube containing the eluted plasmid DNA was either used 
directly in applications such as cloning or sequencing or stored at –20°C for 
later analysis.        
Plasmid DNA sequencing: 
The sequencing reaction conditions were given below at Table 2.4.  
Table 2.4: Sequencing reaction conditions. 
 
*BigDye® Terminator v3.1 Cycle Sequencing Kit from Applied Biosystems. 
Sodium acetate-Ethanol precipitation was applied to the PCR products before 
sequence analysis. 
1. 1 µl 3M pH 4.6 sodium acetate and 25 µl 95 % ethanol were mixed for each 
sample. 
2. 26 µl mixture was added into each PCR product and samples were incubated 
on ice for 15 min. 
3. After incubation, samples were centrifuged for 15 min at 14000 rpm. 
4. Supernatant was discarded and DNA pellet was washed with 250 µl cold 70% 
ethanol. 
5. Samples were centrifuged for 15 min at 14000 rpm. 
6. Ethanol was discarded and samples were incubated for 5 min at 95oC for the 
evaporation of all residual ethanol. 
 
45 
7. DNA was dissolved in 20 µl Hi-Di Formamide. 
8. Samples were denatured by first putting at 95oC for 5 min and then at -20oC. 
ABI 3100 Avant (PE, Applied Biosystem, CA) automated sequencer was used for 
DNA sequencing.   
2.2.3.2 QBP1-pETBlue2 construction 
pETBlue-2 (Novagen) vector has been chosen as the host vector for construct 
formation. QBP-1 oligo was enzyme digested from the pGEM-T cloning vector and 
ligated into pETBlue-2 expression vector. QBP-1 vector is ligated into the host 
vector in a way that any functional protein can be added downstream of the QBP-1 
oligo. When expressed, the fusion protein has the oligo part at N terminal and the 
desired protein at the C terminal, fused to each other.  
Restriction enzyme digestion of pGEM-T-QBP-1/ pCR2.1-TOPO-QBP1 and 
pETBLUE-2 vectors: Both vectors are digested with the same restriction digestion 
enzymes, BglII and EcoRI (Fermentas). Next, they are loaded into agarose gel and 
following the isolation of the DNA fragments from gel, we have QBP-1 oligo and 
pETBlue-2 ready to ligate with sticky ends.   
Table 2.5 : Restriction Enzyme Digestion Conditions. 
 
Reaction conditions: The reactions were incubated at 37°C for 4 hours and 15 
minutes at 65C for enzyme inactivation. Digestion reactions were run on 1-2.5% 
agarose gel electrophoresis and the desired QBP1 and pETBlue-2 sequences were 
extracted from the gel according to previously described procedure. 
Ligation of QBP-1 oligo into pETBlue-2: pCR2.1-TOPO TA cloning vector was 
digested with restriction enzymes and desired DNA fragment was gel extracted. 
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Insert DNA which was cleaned and concentrated was ligated into pETBlue-2 
expression vector. Procedure is described in detail below. 
Ligation reaction was performed with Quick Ligation™ Kit (New Enland Biolabs, 
Inc., Catalog # M2200S) 
1. 1 µl (60 ng) pETBlue-2 vector was combined with 1 µl (5 ng) of insert (3-
fold molar excess). Volume was adjusted to 10 µl with dH2O. 
2. 10 µl of 2X Quick Ligation Buffer was added and mixed. 
3. 1 µl of Quick T4 DNA Ligase was added and mixed thoroughly. 
4. Centrifuged briefly and incubated at room temperature (25°C) for 15 minutes. 
5. Chilled on ice and transformed or stored at –20°C for longer storage. 
6. It was not heat inactivated bacause heat inactivation dramatically reduces 
transformation efficiency.   
Transformation of pETBlue2-QBP1 into host cells: The newly formed pETBlue2-
QBP1 vector was transformed into JM109 and TOP10 competent cells as described 
before (in section 2.1.1.4.)  and colony selection was performed. 
3 µl of the ligation reaction was transformed into a vial of One Shot TOP10 
chemically competent E. coli cells as previously described. Plates were incubated 
overnight at 37°C.  
White colonies obtained subsequent to transformation were selected and incubated 
overnight in 5 mL LB containing 100 µg/mL ampicillin. 700 l of this bacterial 
culture was mixed with 300 l 50% glycerol and stored at –80oC. Plasmid DNA was 
purified from 4 mL bacterial culture for sequencing and further applications by High 
Pure Plasmid Isolation Kit as previously described. 
The purified plasmids were sequenced using BigDye® Terminator v3.1 Cycle 
Sequencing Kit from Applied Biosystems according to the protocol given before and 
the sequence was verified. 
Sodium acetate-Ethanol precipitation was applied to the PCR products before 
sequence analysis as previously described. ABI 3100 Avant (PE, Applied Biosystem, 
CA) automated sequencer was used for DNA sequencing. 
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2.2.3.3 Construction of pETBlue2-QBP1-GFPuv and pETBlue2-QBP1-AP  
pETBLUE-2 vector serves as the host where the QBP-1 oligo and a functional 
protein meets to form a fusion protein. DNA sequences of GFPuv and alkaline 
phosphatase (AP) proteins were amplified from  pGFPuv and pSB2991 plasmids, 
respectively, with the addition of required enzyme cutting sites. The sequences were 
first ligated into pGEM-T cloning vectors and then enzyme digested for ligating into 
previously formed pSilTAG vector to form the fusion proteins. The pSilTAG vector 
containing fusion of QBP-1 and functional protein was transformed into Tuner pLacI 
and Bl21 (DE3) Star competent cells for the protein expression studies.   
2.2.3.4 Construction of QBP1-lcc1  
For the formation of QBP1-lcc1 fusion molecule at the DNA level, firstly, 2 primers 
were designed and commercially synthesized (Alpha DNA/Quebec/Canada). 
Forward primer was a long, 75 base containing primer which contained EcoRI 
enzyme restriction site and QBP1 sequence. The primer binds on 5’ end of lcc1 gene. 
Reverse primer binds on the 3’ end of lcc1 gene and contains NotI enzyme restriction 
site. The template DNA was pPICZ-B plasmid vector containing lcc1 gene. The 
details of the primers are given in the Appendix section. 
PCR (Polymerase Chain Reaction) amplification: Optimized PCR conditions to 
amplify lcc1 gene with QBP1 at 5’ end was as followed: Initial denaturation at 95oC 
for 1 min, denaturation at 95
 o
C for 1 min, annealing at 60 
o
C for 1 min, extension at 
72
 o
C for 1 min and final elongation at 72
 o
C for 5 min. 30 cycles of reaction was 
performed using Pfu polymerase enzyme (Fermentas). 
Amplified DNA was run on 1% agarose containing jel (in TBE 
Buffer:Tris/Borate/EDTA) and extracted from gel by using QIAquick Gel Extraction 
Kit.  
Ligation of QBP1-lcc1 oligo into cloning vector (pDrive): QBP1-lcc1 oligo was 
then ligated into pDrive cloning vector system (Qiagen PCR Cloning Kit). Ligation 
reactions was set up as following; 5μl of 2X Rapid Ligation Buffer, 1μl of pGEM®-
T (50ng), 2μl of PCR product (8ng), 1μl of T4 DNA Ligase (3 Weiss units/μl) and 
deionized water to a final volume of 10μl. The reactions was mized by pipetting and 
incubated for 1 hour at room temperature. 
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Transformation into host cells: 2μl of ligation reaction was added into a sterile 
1.5ml microcentrifuge tube on ice containing 50μl of thawed JM109 High Efficiency 
Competent Cells. The cells were mixed by gently flicking the tube and placed ice for 
20 minutes. The cells was Heat-shocked for 45-50 seconds in a water bath at exactly 
42°C and returned to ice for 2 minutes. 950μl room temperature SOC medium was 
added to the tubes and incubated for 1.5 hours at 37°C with shaking (~150rpm).  
Plating and colony selection: 100 µl of transformation culture is plated onto the LB 
Agar plates (100μg/ml Amp + Xgal-IPTG) for overnight incubation at 37 ºC. White 
colonies are picked from the plate with a pipette tip  5 ml LB Medium with the 
pipette tip was inoculated Incubation for 4.5 hours at 37 ºC (OD600 : 1.5-5) After 
incubation, 2 ml of culture is mixed with glycerol (15%) and vortexed to keep at -80 
ºC. 
Restriction enzyme digestion of pDrive-QBP1-lcc1 and pPICZ-B vectors: Both 
vectors were digested with the same restriction digestion enzymes, EcoRI and NotI 
(Fermentas). Next, they are loaded into agarose gel and following the isolation of the 
DNA fragments from gel, we have QBP1-lcc1 oligo and p-PICZ-B ready to ligate. 
Ligation of QBP1-lcc1 oligo into pPICZ-B vector: Enzyme digested QBP1-lcc1 
oligo and pPICZ-B sequences were ligated by using Quick Ligation Kit (New 
England Biolabs/ABD) as followed; 50 ng of digested vector was combined with a 3-
fold molar excess of digested insert. The volume was adjusted to 10 μl with dH2O 
and 10 μl of 2X Quick Ligation Buffer was added and mixed. 1 μl of Quick T4 DNA 
Ligase was added, mixed and incubated at room temperature (25°C) for 5 minutes.  
Transformation of pPICZ-B (QBP1-lcc1) into bacterial host cells: The newly 
formed vector was transformed into TOP10 competent cells as described before (in 
section 2.1.1.4.) and colony selection was performed. The sequence of newly formed 
fusion vector was checked before transforming into Pichia pastoris yeast cells.  
The purified plasmids were sequenced using BigDye® Terminator v3.1 Cycle 
Sequencing Kit from Applied Biosystems according to the protocol given before and 
the sequence was verified. 
 
49 
Sodium acetate-Ethanol precipitation was applied to the PCR products before 
sequence analysis as previously described. ABI 3100 Avant (PE, Applied Biosystem, 
CA) automated sequencer was used for DNA sequencing. 
Transformation of pPICZ-B (QBP1-lcc1) into yeast host cells: pPICZ-B (QBP1-
lcc1) vector was transformed into Pichia pastoris yeast cells as written in Pichia 
Expression Kit (Invitrogen) and colonies were selected on Zeocin containing medias. 
2.2.4 Protein based studies 
2.2.4.1 QBP1-GFPuv and QBP1-AP expression in  Eschericia coli 
 
pSilTAG vectors (pETBlue2-QBP1) containing GFPuv and AP proteins were 
transformed into Tuner (DE3)pLacI and BL21 (DE3)Star (Novagen) host cells. 
Different expression procedures were tried;  
Firstly, 3 ml of LB media plus 1% glucose plus antibiotics (ampicillin: 50ug/ml 
and/or chloramphenicol: 34 ug/ml) in a culture tube was inoculated with a sterile 
loop of cells taken from glycerol stocks of Tuner (DE3)pLacI and BL21 (DE3) cells 
(2 sets of experiment). The culture was incubated at 37°C with shaking at 250 rpm to 
an OD600 of approximately 0.6–1.0 and stored overnight at 4°C. The following 
morning, the cells was collected by centrifugation and resuspended in 3 ml fresh 
medium plus 1% glucose plus antibiotic(s) and this culture was used to inoculate 100 
ml medium plus 1% glucose plus antibiotic(s) (in another sets of experiments, this 
step was repeated without addition of 1% glucose). The 100-ml culture was shaked at 
37°C until the OD600 is approximately 0.5–1.0. Just prior to induction, the 100-ml 
culture was splitted into 10-ml cultures. For full induction,  IPTG was added to 0, 
0.05, 0.1, 0.5, 1 and 3 mM. The cultures were incubated with shaking at 37°C for 10 
more hours. After 3rd, 6th and 10th hours, samples were taken from each cultures for 
SDS-PAGE analysis.  
As a second way, the transformed cells were grown in LB media plus 0-1% glucose 
plus antibiotics (ampicillin: 50ug/ml and/or chloramphenicol: 34 ug/ml) for 16 h by 
shaking vigorously at 37°C. Then the bacterial cells were collected by centrifugation 
at 2,000 x g for 20 min at 4°C. The bacteria were resuspended in LB medium 
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with/without glucose. IPTG was added to the final concentration of 0, 0.1, 0.5 and 1 
mM. The samples were analyzed by SDS-PAGE. 
As a third way, MagicMedia™ E. coli Expression Medium was also used as an 
alternative. 2-10 ml LB + antibiotic was inoculated with an expression colony and 
incubated overnight at 37°C, 300 rpm shaking. Pre-warmed complete MagicMedia™ 
+ antibiotic was inoculated with overnight culture at a 1:40 dilution. The culture was 
incubated at 37°C (for AP), and 30°C (for GFPuv) 300 rpm 18-24 hours.  
Protein expression analysis: It is important to determine whether the protein is 
soluble in the cytoplasm or located in cytoplasmic inclusion bodies to set up the best 
purification strategy. Many proteins, when they are expressed at high levels in 
bacteria, form inclusion bodies while others are tolerated well by the cell and remain 
in the cytoplasm in their native configuration. 
Determination of target protein solubility: 
1. A single colony from a freshly streaked plates from glycerol stocks of Tuner 
(DE3) PlacI harboring pETBlue-2-GFPuv or pETBlue-2 were picked up and 
inoculated into 5 ml LB medium containing 50μg/ml ampicillin and 34µg/ml 
chloramphenicol in 50 ml Falcon tube to analyze the target protein production 
and its solubility. Culture was grown overnight at 37°C or 30°C with shaking 
at 250 rpm. 
2. 50 ml pre-warmed LB containing 50 μg/ml ampicillin and 34µg/ml 
chloramphenicol was inoculated with 0.5 ml of the overnight culture and 
grown at 37°C or 30°C with vigorous shaking (250 rpm) until the OD600 was 
0.5-0.8.   
3. 1 ml sample was taken immediately before induction (noninduced control). 
The cells were centrifuged at 14.000 rpm and the pellet was resuspended in 
50 μl 1xSDS-PAGE sample buffer. The sample was frozen at –20°C until 
needed for SDS-PAGE.  
4. Cells were induced with 0.1-1.0 mM IPTG and incubated for 3 to 12 hours at 
37°C or 30°C. 
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5. 1 ml sample (induced control) was taken each hour and centrifuged. Pellets 
were resuspended in 100 μl 1x SDS-PAGE sample buffer and frozen at –
20°C until needed for SDS-PAGE. 
6. Cells were harvested by centrifugation at 4 000 x g for 20 min. Cell pellet 
was resuspended in 50 µl of lysis buffer and 3 µl of lysozyme (25 mg/ml) 
was added to the sample.   
7. Cell lysate was sonicated 6 x 10 s with 10 s pauses at 400 W on ice. Lysate 
was centrifuged at 10 000 x g at 4°C for 25 min. The supernatant was 
decanted (soluble protein) and saved on ice. 
8. The pellet was resuspended in 50 µl of lysis buffer which constitutes the 
suspension of insoluble matter (insoluble protein). 
9. 50 μl of 2xSDS-PAGE sample buffer was added to each of the soluble protein 
and insoluble protein extract. 
10. Samples were heated with the frozen noninduced and induced cell samples at 
95°C for 5 min. 
Induced, non-induced and 2.5 ml of soluble protein mixtures were centrifuged at 
15.000 x g for 1 min. All the samples were stored at –20°C until SDS-PAGE 
analysis.   
SDS-PAGE analysis of fusion expression: Sodium dodecyl sulphate 
polyacrylamide gel electrophoresis (SDS-PAGE), was carried on a 12.5 % separating 
gel and a 5 % stacking gel. Electrophoresis was run two hours with a voltage of 120 
mV. Protein bands were stained with Coomassie brilliant blue R250. Gels were then 
destained with a mixture of acetic acid and ethanol (5%; 10%). The Protein 
Molecular Weight Marker mix (SM #0431) included; β-galactosidase (116 kDa), 
bovine serum albumin (66.2 kDa), ovalbumin (45 kDa), lactate dehydrogenase (35 
kDa), endonuclease Bsp 981 (25 kDa), β-lactoglobin (18.4 kDa) and lysosym (14.4 
kDa). The gel components are given in Tables below. 
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Table 2.6 : Components of Lower Resolving Gel (12% Acrylamide/Bis-acrylamide). 
 
Prepared solution was poured into the gel casting forms provided that leaving 2 cm 
below the bottom of the comb for the upper stacking gels. Top of the gels were 
layered with 200 ul isopropanol to remove the bubbles. After the polymerization of 
the lower resolving gels, isopropanol was washed out completely. 
 
Table 2.7 : Components of Upper Stacking Gel (5 % Acrylamide/Bis-acrylamide). 
 
Prepared upper stacking gel solution was poured on the top of the lower resolving 
gels and combs were inserted. After this, gels were allowed for complete 
polymerization. 12 ul of each sample obtained in purification steps were mixed with 
6 ul of 3X SDS loading dye and boiled for 5 min at 95 °C for protein denaturation. 
After loading all the samples and protein marker (Fermentas, Appendix D) to the gel 
lanes, gels were run at 80 volt for upper stacking gels and 140 volt for lower 
resolving gels until the loading dyes reached the bottom of the gels. 
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Visualization of the protein bands were accomplished by staining the gels with 100 
ml of gel stain solution (Appendix B) with shaking at 40 rpm for 1 hour at 37 °C. 
Finally, gels were destained by 100 ml of gel destain solution (Appendix B) with 
gentle shaking at 30 rpm for 2 hours at 37 °C. 
2.2.4.2 QBP1-lcc1 expression in Pichia pastoris  
Pichia pastoris colonies containing pPICZ-B (QBP1-lcc1) were selected. For the 
expression of fusion proteins, Pichia Expression Kit (Invitrogen) has been followed.  
25 ml of BMGY medium was inoculated using a single colony in a 250 ml flask and 
grown at 30°C in a shaking incubator (250 rpm) until culture reached an OD600 = 2–
6. The cells were harvested by centrifuging at 2000 g for 5 minutes at room 
temperature. Supernatant was decanted and cell pellet was resuspended to an OD600 
of 1.0 in BMMY medium to induce expression (approximately 100–200 ml). 100% 
methanol was added to a final concentration of 0.5% every 24 hours to maintain 
induction. 1 ml of the expression culture was transferred to a 1.5 ml microcentrifuge 
tube to analyze expression levels. 
2.2.5. Assays 
2.2.5.1 Laccase enzyme activity assay 
ABTS (2,2'-azino-bis(3-ethylbenzthiazoline-6-sulphonic acid)) is the substrate used 
to observe the reaction kinetics of laccase. Laccase enzyme facilitates the reaction of 
ABTS with hydrogen peroxide, turning it into a green and soluble end product which 
gives absorbance maximum of 420 nm light. 3 selected colonies and control group 
were induced for 5 days, and samples of every 24 hours were collected and mixed 
with ABTS (2.5 mM) in NaCitrate (pH.3.0, 30mM) buffer. Enzyme kinetics 
experiment was performed at 421 nm of light.  
2.2.5.2 BCA assay 
Microplate procedure (sample to working reagent-WR ratio = 1:8) 
The procedure for BCA assay is as follows: 
 
54 
1. Pipette 25 μl of each standard or unknown sample replicate into a microplate well 
(working range = 20-2,000 μg/ml). 
However, the working range of the assay in this case will be limited to 125-2,000 
μg/ml. 
2. Add 200 μl of the WR to each well and mix plate thoroughly on a plate shaker for 
30 seconds. 
3. Cover plate and incubate at 37°C for 30 minutes. 
4. Cool plate to RT. 
5. Measure the absorbance at or near 562 nm on a plate reader. 
6. Subtract the average 562 nm absorbance measurement of the Blank standard 
replicates from the 562 nm measurements of all other individual standard and 
unknown sample replicates. 
7. Prepare a standard curve by plotting the average Blank-corrected 562 nm 
measurement for each BSA standard vs. its concentration in μg/ml. Use the standard 
curve to determine the protein concentration of each unknown sample. 
2.2.6. Preparation of silica and quartz resin  
 Around 100 mg (for batch), 1-2 g (for column) of silica/quartz powder was 
weighed. 
 Serial washing steps were applied by using 50 % isopropanol and distilled water. 
 Powder samples were vortexed for 5-10 min and then sonicated for 20 min in the 
ultrasonic bath. 
 The powder was vortexed quickly to resuspend and spinned down at 200 g for 3 
min. 
 After washing steps, 0-0.5 % PC buffer was added to equilibrate the resin 
surface. 
2.2.7 Column packing / batch procedure 
For the purification steps, both column and batch procedures were applied. After the 
silica/quartz resin was cleaned, it was poured into empty purification columns and 
waited to settle down. In column case, the samples and buffers were run through the 
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column using peristaltic micro-pump to arrange the liquid flow speed. The system is 
given in Figure 3.26. For the batch application, the samples can be introduced with 
resin material in a micro centrifuge tube. Washing and elution buffers were applied 
onto the resin material in the micro centrifuge tube, and after incubation period, the 
resin was precipitated using centrifugation. 
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3.  RESULTS AND DISCUSSION                
3.1. Bacterial Cloning and Expression Systems (E.coli) 
3.1.1 Cloning optimization 
3.1.1.1 QBP1 oligo construction 
To use QBP-1 peptide as N-terminal fusion molecule, bacterial cloning and 
expression systems have been selected as host systems. The idea is forming a QBP1-
functional protein fusion molecule at the DNA level and transform it into a bacterial 
host system (e.g. Eschericia coli) and express the fusion molecule for later use. At 
the end, QBP1 peptide can be used as a “tag” molecule for the purification of 
functional protein from cell extract using silica/quartz resin. 
For the formation of the vector systems at the DNA level, 3 parts were needed to be 
brought together. The first one was a host vector, pETBLUE-2 (or pQE60), which 
serves as a place where QBP-1 oligo and a desired functional protein can form a 
fusional protein. So the experimental work starts with the design of QBP-1 oligo 
which includes previously selected QBP-1 peptide sequence, a designed 14 aa linker 
(proline and glycine rich) to hold the QBP-1 peptide out of the functional protein, 
Factor Xa and restriction enzyme cutting sites. 
The QBP1 oligo complex contains the basic parts for different purposes. The 
restriction enzyme cutting sites form the necessary positions for relocation of the 
oligo complex in other expression systems. QBP1 oligo is followed by a 14 amino 
acid long linker sequence. The idea of using a linker sequence is basically; when the 
protein fusion molecule is formed, with the help of the linker molecule, QBP1 
sequence can easily be hold outside of the protein. So QBP1 peptide can freely bind 
on the resin material. The composition of linker (spacer) sequence is formed just 
theoretically, including proline and glycine residues. Prolines help to form a rigid 
structure and glycine is needed for some flexibility. The last part is Factor Xa cutting 
site. When the fusion molecule is expressed and purified by using silica/quartz resin, 
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QBP1-functional protein fusion molecule is obtained. If necessary, QBP1 oligo can 
be separated from functional protein by using Factor Xa enzyme which recognizes 
IEGR sequence and cuts the protein. This is an optional choice. If the tag molecule 
does not affect the activity of the functional protein, it can stay on N-terminal of the 
protein and there is no need for Factor Xa usage. If there is an effect of QBP1 
molecule on the functionality of the protein, Factor Xa can be used to separate them 
and the parts can be run through silica resin for a final step.   
 
Figure 3.1: QBP1 oligo includes QBP-1peptide, 14 amino acid spacer and Factor Xa 
Protease Cleavage Site.  
When expressed, QBP-1 peptide will have just a methionine residue at the N 
terminal end. Here, Figure 3.1 shows the designed QBP-1 oligo sequence which will 
be placed at the N-terminal end of the functional protein. The oligo basically 
includes a start codon for methionine residue, 12 amino acid long QBP1 sequence, 
14 amino acid  long spacer which is rich in proline and glycine, and finally Factor Xa 
cutting site for later protease digestion of fusion molecule. The final construct is 
given schematically in Figure 3.2.  
 
Figure 3.2: Schematic presentation of QBP1-Functional protein fusion molecule 
which includes QBP-1peptide at N-terminal, functional protein 
(GFPuv/AP) at C-terminal and 14 amino acid spacer and Factor Xa 
Protease Cleavage Site in between.  
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So, the experimental procedure starts with the design of QBP1 oligo complex. 
Because the designed oligo was synthesized commercially as ssDNA, it was needed 
to be turned into ds form before ligating into the host vector. It is a short one that is 
why the conditions for the amplification need to be carefully optimized. 
PCR optimization for QBP1 oligo: Figure 3.3 shows the amplified ds oligo QBP-1 
around 150 base long marker DNA. Dealing with a short DNA sequence can be 
problematic. In our case, the main problem is the very high GC content of QBP1 
oligo with spacer sequence. About 80% GC content of the oligo makes the PCR 
protocol extremely problematic. The annealing temperature of the primers must be 
carefully optimized for getting a sharp DNA band on the gel for later use. Because of 
the high GC content, the oligo has a very high melting temperature which overlaps 
with the working temperature of the polymerase enzyme. Best ways to decrease the 
melting temperature is using agents such as betain, GC-melt or DMSO which will 
inhibit the formation of secondary structure in DNA template and primers, and 
proceed the PCR reaction.   
 
              
 
Figure 3.3:  Agarose gel electrophoresis image: ssDNA oligo was PCR amplified 
and turned into dsDNA before the ligation step.  On the left; Marker 10 
and amplified oligo was seen around 140 bp. On the right; there is 
Marker 10 and amplified oligo with 10% DMSO (lane 2-3 with 
different template amounts) usage in PCR reaction. (PCR with Taq 
enzyme and 61°C annealing temperature). 
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We have also tried Klenow reaction to synthesize dsDNA from single stranded oligo 
but a sharp bant could not be achieved. The best result was obtained by using DMSO 
in the PCR reaction. The later part is the colony screening for the sequence without 
mutation. 
Ligation into cloning vector: Amplified ds QBP-1 oligo was ligated into a cloning 
vector, pGEM-T, and transformed into appropriate host cells. These vectors 
including QBP-1 oligo, (Figure 3.4) can now be used as a kind of library for the 
formation of any desired fusion protein. QBP-1 and/or the linker part can just be 
enzyme digested or PCR amplified according to the needs of another system to form 
the fusion constructs. This kind of libraries was prepared for each component which 
was necessary in our systems, such as QBP-1 oligo, a differentiated QBP-1 oligo 
with linker sequence or functional proteins (GFPuv, AP and lcc1). 
 
 
 
 
 
 
 
 
Figure 3.4:  (On the left) Agarose gel electrophoresis image for pGEM-T-QBP-1 
vectors acting as library for QBP1 sequence for any later ligation 
process for different functional proteins. (On the right) After all the 
ligation procedures, the sequences were verified by sequence analysis to 
check if there is any mutation in the sequence.  
The next step was the ligation of QBP-1 oligo into pETBLUE-2 (or pQE60) host 
vector where any functional protein can be added to C terminal of the linker peptide 
to form the construct. Figure 3.4 shows the single digestion (EcoRI) of the ligation 
product around 3600 bp DNA  marker. This vector is now the main expression vector 
for addition of any desired protein, so at the end the protein will have an N terminal 
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QBP-1 tag with 14 aa spacer molecule. In the ligation step, the main problem is the 
low amount of QBP1 oligo DNA before ligating into host vector. Theoretical 3:1 
molar ratio rule is not always in use for the ligation protocol. The ratio starts from 
1:1 to 9:1 which makes obtaining the necessary amount of oligo DNA difficult. 
 
 
Figure 3.5: Agarose gel electrophoresis image for single eznyme digested (EcoRI) 
pETBlue-2 vector including QBP-1 oligo.  
3.1.1.2 Addition of functional proteins at the dna level: recombinant green 
fluorescent protein (GFPuv) and alkaline phosphatase (AP)  
The DNA sequences of GFPuv and AP was obtained from pGFPuv and pSB2991 
vectors respectively, by PCR amplification with the addition of necessary enzyme 
cutting sites. The sequences were first ligated into pGEM-T cloning vector to form 
the library for each of them. The sequences were then enzyme digested and ligated 
into host vectors such as pETBLUE-2 and pQE60, host vector containing QBP1 
oligo complex for the protein expression studies. 
Working with GFPuv and AP is much easier than working with QBP1 oligo at the 
DNA level. GFPuv is 717 bp long and AP is 1434 bp long which are long enough at 
the DNA level for PCR, enzyme restriction or ligation. If necessary, AP or GFPuv 
proteins can be replaced by any desired protein for expression process.   
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Figure 3.6 Agarose gel electrophoresis image for pETBlue–2 (QBP1-GFPuv). On 
the left; double digested pETBlue2(+QBP1) and GFPuv sequences in 
which QBP1 first ligated to host vector and then GFPuv was ligated to 
pETBlue2(+QBP1), in the middle; QBP1 and GFPuv were ligated first 
and then were placed into host vector, on the right; single and double 
digested full vector pETBlue2(+QBP1+GFPuv). 
 
Figure 3.7 Agarose gel electrophoresis image for double digested (NcoI and 
HinDIII) pQE60 and QBP1-AP sequences. 
 
The final construct structure can be shown in Figure 3.8. pETBlue-2 vector (or 
pQE60) acts as host vector at the DNA level for QBP1-GFPuv and QBP1-AP fusion 
molecules, or any desired fusion structures. 
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Figure 3.8.  pETBlue2 (or pQE60) acts as the host vector to form GEPI-Functional 
         protein fusion molecules. 
3.1.2 Expression optimization 
Although working at the DNA level can be tricky or problematic, the critical point is 
the expression of the QBP1 tagged protein. The tag molecule is located at the N 
terminal of the protein. The reason why it is located at that way, when quartz binding 
peptides were selected, they are located at the N terminal of the phage proteins. 
Change of direction of tag molecule might have an effect on the level of binding on 
the silica resin, that is why, the tag molecule is located at the N terminal position in 
the vector systems.  
3.1.2.1 QBP1-GFPuv  
There can be many parameters affecting the expression of the protein in the cell. The 
type of the cell, the media used for the incubation, the temperature and time ranges 
and the composition of the DNA sequence are the main affecting factors. What we 
are doing is, checking as much as possible parameters and limiting the possible 
effective steps on the expression. 
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The formed QBP1+GFPuv vector system was transformed into 2 different host cells, 
Tuner (DE3) pLacI and BL21(DE3)Star, for the protein expression studies. Each 
protein and each vector system needs its own optimized expression conditions. 
Different media, temperatures, IPTG concentrations etc. were tried. These are the 
parameters affecting the level of protein expression which must be optimized. 
pETBLUE-2 system generally needs a host cell with an extra pLacI plasmid for the 
tight control of protein expression.  
The protein is supposed to be in soluble portion of the extract, and also maximum 
expression is expected around 30°C and 300 rpm shaking. Temperature was 
decreased from 37°C to 30°C to slow the increase in cell number but to have a high 
level of expressed protein. 
 
 
Figure 3.9.  SDS-PAGE image for pETBlue2-QBP1-GFPuv expression in Tuner 
(DE3) pLacI cells at 30°C. 
 
Addition of alanine as the second amino acid: Due to the failure in protein 
expression after trying several cell lines, temperature and IPTG ranges, DNA 
sequence has been modified. The new vector system was formed by similar 
experimental procedures as in the first vector system. In the first vector system, 
QBP1 oligo comes after the first methionine residue. It is a differentiated form of 
pETBLUE-2 vector in a way that the expressed QBP-1 peptide has just an extra 
methionine residue at the N terminal, aiming not to affect the binding of QBP-1 on 
the silica surface. 
But in the modified vector system, QBP-1 oligo was PCR amplified in a way that an 
alanine residue was added as the second amino acid after the first methionine 
residue, as recommended in pETBLUE-2 system. It produces QBP-1 peptide with 
extra methionine and alanine residues at the N terminal. The reason for that is to 
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optimize the vector efficiency during the protein expression, but on the negative side, 
this extra alanine can affect the binding of the QBP-1 on the silica surface.      
 
 
Figure 3.10: Alanine residue has been added as the second amino acid in front of 
QBP1 sequence. 
 
                                 
Figure 3.11: (On the left) Agarose gel electrophoresis images: Direct PCR and use 
of GC-Melt for PCR Reaction, (On the right); 5% and 10% DMSO for 
Site Directed Mutagenesis for Addition of Alanine Residue, (annealing 
80ºC, Pt HiFi enzyme). 
Effect of linker sequence: QBP1-GFPuv (without linker): As a second 
modification to the vector system, to increase the efficiency of the expression of the 
fused proteins, linker sequence has been removed from the system. 
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Figure 3.12: QBP1-Functional Protein Sequence Structure without 14 aa spacer 
sequence. 
The new system has the pETBlue-2 vector as the host vector as in previous vector 
systems but 14 aa long linker peptide between QBP1 peptide and the functional 
proteins were deleted. QBP1 peptide directly binds with the functional proteins. Two 
versions of the vector system were created, one containing AP (alkaline phosphatase) 
and the other one containing GFPuv as the functional protein. Molecular biology 
procedures were followed as given in Section 2 to form the constructs. After the 
formation of the vector products, they were transformed into host cells such as Tuner 
(DE3) pLacI, BL21 (DE3) Star for the protein expression experiments. Different 
media such as 2YT, LB and commercial Magic Media (Invitrogen) were tried to 
optimize the protein expression conditions.  
 
Figure 3.13 Schematic represantation of QBP1-GFPuv construct protein after 
removal of 14 amino acid spacer sequence and addition of Alanine (A) 
residue as second amino acid.  
 
The schematic represantation of construct protein after removal of 14 amino acid 
spacer sequence and addition of Alanine (A) residue as second amino acid were 
given in Figure 3.13.  
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The best result obtained was the QBP1+GFPuv fusion protein, with alanine added as 
the second amino acid, in the BL21 (DE3) Star cells, after 21 hours of induction in 
MagicMedia solution as given in Figure 3.14.  
 
 
Figure 3.14 Unmodified/Modified Vector systems , pETBlue2-QBP1-GFPuv in the 
BL21(DE3) Star cells, after 21 hours of induction in MagicMedia 
solution.Lane1: Protein marker, Lane 2-4: t=10 hrs of induction, C, VS 
(+linker) and VS (-linker), Lanes 5-7: t=21 hrs of induction, C, VS 
(+linker)  and VS (-linker). (C: Tuner (DE3) pLacI with a control 
pETBLUE-2 vector,  VS1: Vector System with linker and VS2: 
Vector System without linker.  
When the vectors including GFPuv functional protein with/without linker sequences 
were expressed in different host cells and culture media, there was still problem of 
expressing the protein. The best results obtained were with using commercial 
MagicMedia solution and after 21 hours of incubation. But the problem is that, the 
results were not repeatable. After applying the same experimental conditions, similar 
results were not obtained. GFPuv is a small protein in a hollow-cylindirical structure. 
One possible explanation of low expression level might be the affect of QBP1 
peptide during the translation process.  
3.1.2.2 QBP1-AP 
Similar conditions were applied for pETBlue2-QBP1-AP construct. Modifications 
have been applied on DNA sequence. Alanine residue was placed as the second 
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amino acid and 14 aa. linker sequence was removed as shown in Figure 3.15. The 
type of the cell, the media used for the incubation, the temperature and time ranges 
have been tried for an optimized protein expression. 
 
Figure 3.15: Schematic represantation of QBP1-AP construct protein after removal 
of 14 amino acid spacer sequence and addition of Alanine (A) residue as 
second amino acid.  
 
 Figure 3.16: SDS-PAGE gel results for QBP1-AP fusion proteins (no linker) in 
pETBLUE-2, in TUNER cells.  
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 For AP case, the protein has normally a leading peptide sequnce at the N terminal 
which sends the protein to the periplasmic space. In here, the leading peptide is 
replaced with QBP-1 peptide, that’s why the localization of the protein needs to be 
determined.         
                                   
Figure 3.17: SDS Gel Eectrophoresis Analysis for QBP1-AP (no linker) construct: 
Lane 1: 3 hours of 1mM IPTG induction, pETBlue-2 from TUNER 
(DE3) pLacI cells,  Lane 2: Protein Marker, Lane3: 3 hours of 0,5 mM 
IPTG induction pETBlue-2 (QBP1+AP) from TUNER (DE3) pLacI 
cells, Lane 4: 1mM IPTG induction of construct containing TUNER 
cells. 
As it is seen in Figure 3.16 and Figure 3.17, the QBP1-AP fusion protein was 
produced around 40 kDa length. After 3 hours of induction, the cells were disrupted 
by using lysozyme and the cell extract were run on SDS-PAGE gel. In the 3rd and 
4th lanes, the expressed proteins are shown at about 37–40 kDa range. AP protein is 
normally about 50 kDa and with the addition of QBP1 complex, the fusion molecule 
must be in 51–52 kDa range. But the gel results show a problem in protein 
expression. The translation process might be stopped before producing all protein so 
instead of 51–52 kDa protein, only 37–40 kDa protein is observed. One of the 
possible explanation for this; QBP1 tag molecule could bend and interfere with the 
mRNA molecule during translation process. This might be because of rigid proline 
residues in QBP1 peptid. 
Purification experiments using silica columns, QBP1 acting as tag peptide  
For purification of the QBP1-tagged proteins, silica columns (60–80µm) were 
prepared and cell extract was applied onto the column. The columns were washed 
116 kDa 
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with buffer (pH: 6,4) and the eluted sample was boiled in loading dye before 
applying onto SDS-PAGE gel. 
 
 
                                              
 
 
 
 
 
 
 
 
 
Figure 3.18: (On the left): Silica columns containing 60-80 µm Silica particles. (On 
the right): SDS Gel Electrophoresis Results: Lane 1: After 1 hours of 
incubation of cell extract on silica resin, the non-binding sample. Lane 
2: Protein marker, Lane 3-4: The samples after boiling the resin. 
The experiments previously carried out showed us that QBP-1 peptide is a strong 
silica-binder. 
The results show that a protein which is about 37-40 kDa stayed on the silica resin 
after the washing steps. This protein is most possibly half produced QBP1-AP 
protein which must have a right composition of QBP1 sequence to bind on silica 
resin. When bringing both data together, QBP1-AP fusion molecule is supposed to 
be about in 51-52 kDa range but there is protein expression only in 37-40 kDa range 
which is obtained after purification on silica resin. QBP1 peptide must be formed 
right but the remaining part of the protein is not produced. The amino acid 
composition of QBP1 peptide is most possible reason for that due to high ratio of 
rigid proline residues.  
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3.2. Eukaryotic Cloning and Expression Systems (Pichia pastoris) 
3.2.1. QBP1-lcc1 construct formation 
Laccase gene, lcc1, has been obtained from Pycnoporus sanguineus by our research 
group in a former study. What we are doing here is taking lcc1 gene from 
Pycnoporus sanguineus and fuse it with QBP1 oligo and transform it into Pichia 
pastoris for the expression of QBP1-lcc1 fusion protein. QBP1 peptide 
(PPPWLPYMPPWS) is placed at the N terminus of the laccase enzyme (lcc1) in 
Pichia pastoris yeast cells to form a hybrid fusion molecule. Firstly, fusion protein 
was formed at DNA level and transformed into yeast cells, then the hybrid fusion 
was expressed at protein level.  
For the formation of QBP1-lcc1 fusion molecule at the DNA level, firstly, 2 primers 
were designed and commercially synthesized (Alpha DNA/Quebec/Canada). 
Forward primer was a long, 75 base containing primer which contained EcoRI 
enzyme restriction site and QBP1 sequence. The primer binds on 5’ end of lcc1 gene. 
Reverse primer binds on the 3’ end of lcc1 gene and contains NotI enzyme restriction 
site. The template DNA was pPICZ-B plasmid vector containing lcc1 gene (Figure 
3.19).  
PCR amplified QBP1-lcc1 DNA sequence has been ligated into pDrive cloning 
vector and transformed into JM109 High Efficiency Competent Cells. QBP1-lcc1 
sequence was verified by DNA sequencing and restriction enzyme digested for 
ligation process. 
QBP1-lcc1 oligo was placed into pPICZ-B vector and translated into Pichia pastoris 
yeast cell for expressing the fused QBP1-lcc1 fusion protein. The selected colonies 
were incubated on MM (Minimal Media) plates containing Zeocin as shown in 
Figure 3.20.  
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Figure 3.19: pPICZ-B vector acts as a host for fusion of QBP1 and lcc1 sequences. 
 
Figure 3.20:Three colonies were selected on Zeocin (100 mg/ul) containing Minimal 
media plates (MM).  
The selected colonies will have lcc1 protein with N-terminal QBP1 sequence fused, 
but yet the enzyme activities of each selected colonies may differ from each other. 
All selected colonies need to be checked for enzyme activity levels. 
Enzyme activities can be checked first on MM plates with the addition of ABTS 
chemical substrate. The green color in Figure 3.21 shows that; the three selected 
colonies are expressing laccase protein and releasing outside the cells where the 
enzyme reacts with ABTS and forms a green color which can be easily seen visually.    
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3.2.2 Production of “QBP1 Tagged lcc1” protein and its secretion out of the host 
cell  
The first question when the QBP1-lcc1 construct is formed and transformed into the 
host cell, is whether the tagged enzyme would be produced and secreted outside of 
the cell or not. What we see here is a simple visual presentation of the produced 
tagged enzyme activity outside of the cell. When control cells (Pichia pastoris 
without lcc1), lcc1 containing cells (Pichia pastoris+lcc1) and QBP1-lcc1 cells 
(Pichia pastoris+QBP1lcc1) were grown on YPD media containing ABTS substrate 
of lcc1 enzyme, the blue colour on the plate shows the secreted active enzyme 
outside of the cell.   
 
 
Figure 3.21: Secretion of QBP1 tagged lcc1 protein outside of the cell. C: Pichia 
pastoris, 1: Pichia pastoris (+lcc1), 2–3: Pichia pastoris (QBP1-lcc1) 
QBP1 tag molecule does not affect the production of the enzyme and its secretion out 
of the cell even when it has been located at the N-terminal of the enzyme. 
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Figure 3.22: As the extracellular samples are reacted with 2,5 mM ABTS, the colour 
turns into green according to the level of active enzyme. (Samples are in 
triplets, first two lanes are waited measurings, 3rd and 4th lanes are 
fresh measurings). 
3.2.3 Effect of the “Tag” molecule on the enzyme activity  
After 5 days incubation of control (Pichia pastoris (+lcc1)) and construct (Pichia 
pastoris (QBP1-lcc1)) cells, the enzyme activity levels were compared.  
Methanol was used to induce the protein expression and samples were collected 
every 24 hours for enzyme activity assay. Samples were centrifuged to get the 
extracellular supernatant where the expressed proteins localize.  
Figure 3.23 shows the enzyme activity levels for tagged enzyme (QBP1-lcc1) and 
control sample (lcc1) for five days.  
The results means that tag does not affect the activity of the enzyme. First, the 
activity of the tagged enzyme was a little different from the control sample but after 
5 days of incubation tagged enzyme shows the same level of expression with the 
laccase from the control sample. This shows that QBP1 tag on the N-terminal does 
not have a significant effect on the activity of lcc1 enzyme.  
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Day:        
1 2 3 4 5 
lcc1 (U/lt) 43,7 86,18 96,59 133,64 137,9 
QBP-lcc1 (U/lt) 12,49 62,04 78,82 113,85 137,46 
 
Figure 3.23 : Laccase activity levels from selected Pichia pastoris colonies and a 
control sample were compared for five days by reacting laccase 
containing extracellular medium with ABTS and measuring the 
absorbance level spectrophotometrically.  
3.3 Vector Set for QBP1 tagged functional protein systems 
Before starting the details of SilTAG application, all the vector systems have been 
summarized here. For eukaryotic and bacterial cell lines, totally 4 cell types were 
used as host cells to express the vectors containing several versions of QBP1-
Functional protein fusion constructs. DNA sequences for QBP1, AP, GFPuv and lcc1 
alone, or fused, with or without spacer, or Alanine residue,  have been prepared in 
different vectors and  in different host cells, both bacterial and eukaryotic. In case of 
need, any one of them can easily be amplified, or removed and a new sequence can 
be added. The list of host vectors, cells with construct details is given in Figure 3.24. 
Time 
(Days) 
U/lt 
 
76 
 
Figure 3.24 : List of constructed QBP1-Functional protein versions in different host 
cell for eukaryotic and bacterial sources.  
3.4 SIL-TAG application 
3.4.1 Selection of resin material 
Although quartz binding peptides were initially selected by using quartz crystals 
(SiO2), for the purification purpose, different kinds of resin material were applied. 
Crushed glass particles, silica and quartz beads were used to bind the fusion proteins 
on the surface. Silica resin was 60 to 200 µm in diameter and quartz resin was 200-
800 µm in diameter. All resin materials were cleaned with isopropanol, ethanol and 
distilled water in sonic bath before introducing the proteins.  
After expressed in Pichia pastoris cells, QBP1-lcc1 fusion protein is secreted outside 
of the cell. The extracellular solution, including QBP1-lcc1 fusion molecule, was 
applied on to cleaned resin materials, crushed glass, silica and quartz beads. The 
materials were washed several times with PC buffer (pH: 7) solution and beads were 
taken into fresh PC solution for remaining total protein and enzyme activity analysis. 
BCA analysis was applied for measuring the remaining total protein amount on the 
surface and Na-citrate analysis was used for measuring the enzyme activity levels. 
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Figure 3.25: Relative total protein and enzyme activity levels after several wash 
steps of glass, quartz and silica beads which have been incubated with 
QBP1-lcc1  extracellular solution. 
The basic binding experiments show that glass and quartz hold more protein on the 
surface but active anzyme level is more for silica and quartz. For the batch and 
column purification experiments, silica and quartz resins were selected.     
3.4.2 Batch and/or column purification 
Both methodologies can be used for the purification process. The samples can be 
introduced with resin material in an eppendorph tube or the sample can be sent 
through resin packed columns. Here three different forms of purification were tried. 
Simple eppendorph tubes were for the batch application. Samples were run through 
packed columns simply by gravitational force or mircopump system.   
3.4.3 Denatured / Native form of the purified protein 
One of the main advantegous sides of a tag system is its availability to use both in 
purification of desired protein in native or denatured forms. For different 
biotechnological applications, protein can be preferred in denatured or native forms. 
So, a better purification system must be able to purify the proteins in both forms. If 
after the purification process the enzyme is needed in active form, the samples 
should run through the column in native conditions without any denaturing detergent 
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or heat application. There might not be need for preserving the native form of the 
protein, so the enzyme can be first denatured using heat and detergents and then run 
through the column.   
 
Figure 3.26: Mini centrifuge tubes can be used for batch purification (on the left). 
Resin packed columns can be run via gravitational force (in the 
middle), or peristaltic pump (on the right). 
 
3.4.4. Optimization for binding buffer 
Silica powder was used as a resin material for purification assay. The bead size of 
powder was from 60 to 200 um. The powder was cleaned with isopropanol, ethanol 
and distilled water in sonic bath and packed in a column. Extracellular sample 
containing the expressed conjugated protein was taken into PC buffer (4 different pH 
values). After running the extracellular  sample through the column, flowthrough 
samples were collected and enzyme activity levels were measured in sodium citrate 
buffer (laccase activity assay). Below is the tables giving the activity levels and 
protein amounts for each collected flowthrough samples for different pH values.  
Table 3.1 shows the enzyme activity levels for extracellular sample and the 
flowthrough. There is not much loss in enzyme activity levels when pH 6,5-7,5 
buffers were used as binding buffers. As shown in Table 3.2, total protein loss is 
much less with pH 7,5 buffer. Totally, the binding buffer was selected as pH 7.5 
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buffer in which there is not much protein loss to flowthrough and enzyme avtivity 
level is high.  
 
Table 3.1: Enzyme Activity Assay (BCA Assay)-Binding levels of QBP1-lcc1      
        conjugate protein on silica resin for 4 different pH values. 
 
Input  
(U) 
Flowthrough  
(U) Binding Percentage % 
pH:5.5 
0,04329 0,01369 68 
pH:6.5 
0,02525 0,0006 98 
pH:7.5 
0,01975 0,0004 97 
pH:8.5 
0,01537 0,0036 76 
 
Table 3.2: Total Protein Amount -Binding levels of QBP1-lcc1 conjugate protein on 
        silica resin for 4 different pH values. 
 
Control  
(mg) Flowthrough (mg) 
Binding Percentage  
% 
pH:5,5 0,76 0,09 87,38 
pH:6,5 0,76 0,15 79,81 
pH:7,5 0,68 0,07 90,04 
pH:8,5 0,62 0,13 78,74 
 
Table 3.3 is showing specific activity levels meaning low level of QBP1-lcc1 fusion 
molecule in flowthrough sample for pH 6,5-7,5 buffers. 
The graph given below shows the binding percentage levels for each different pH 
values. Acoording to the results, PC buffer (pH: 6,5 and pH:7.5) are suitable as 
binding buffer. The extracellular sample which includes the conjugate protein must 
first transferred into the optimum binding buffer. 
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Table 3.3: Specific Activity Levels-Binding levels of QBP1-lcc1 conjugate protein 
        on silica resin for 4 different pH values. 
 
Control  
(U/mg) Flowthrough (U/mg) 
pH:5,5 0,057 0,15279 
pH:6,5 0,03322 0,004 
pH:7,5 0,02892 0,0058 
pH:8,5 0,02479 0,02753 
 
 
 
Figure 3.27: Binding levels of QBP1-lcc1 conjugate for different pH values. 
3.4.5. Optimization for washing buffer 
To find an optimum wash buffer, extracellular sample was first transferred into 
optimum binding buffer (PC buffer, pH: 7.5) which was given in the previous 
section. 
After binding is complete, the column is washed with PC buffer (pH: 6.5 or pH: 7.5). 
As given in the next table, PC buffer (pH: 6.5) acts well as a wash buffer.  
PC buffer (pH.7.5) was used as binding buffer and PC buffer (pH.7,5 + 
0.5%Tween20) was used as washing buffer. The extracellular protein sample was in 
PC buffer (pH.7,5) to have the protein in native form, or in PC buffer (pH.7,5 + 8M 
Binding  
Percentage     
% 
pH 
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Urea) to have the protein in denatured form, to see the effect of protein folding on 
binding level. 
 
Table 3.4: Total Protein Amounts after Wash Steps - QBP1-lcc1 conjugate protein 
       on silica resin for 2 different pH values. 
 
 
 
 
Table 3.5: Protein Activity Level- wash buffers on binding levels. 
 
 
 
 
 
Table 3.6: Specific Activity-Effects of wash buffers on binding levels. 
 Control Sample (U/g) Flowthrough (U/g) 
pH:6.5 29,82 7,94 
pH:7.5 32,7 35,36 
 
Binding and washing conditions were optimized showing pH 7.5 as the best binding 
pH and 6.5 as better washing pH condition.  
The graph given below shows the binding percentage levels for each different pH 
values. Acoording to the results, PC buffer (pH: 6,5 and pH:7.5) are suitable as 
binding buffer. The extracellular sample which includes the conjugate protein must 
first transferred into the optimum binding buffer. 
To find an optimum wash buffer, extracellular sample was first transferred into 
 
Control  
(mg/ml) 
FT+Wash  
(mg/ml) 
Binding 
Percentage % 
pH:6.5 0,73 0,32 55,75 
pH:7.5 0,51 0,11 79,21 
 
Control Sample 
(U/lt) 
Flowthrough 
(U/lt) 
Binding 
Percentage % 
pH:6.5 21,77 2,54 88 
pH:7.5 16,68 3,89 76 
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optimum binding buffer (PC buffer, pH: 7.5) which was given in the previous 
section. After binding is complete, the column is washed with PC buffer (pH: 6.5 or 
pH: 7.5). 
As given in the next table, PC buffer (pH: 6.5) looks better as a wash buffer.  
Effect of pH on enzyme activity: Another result from here is the effect of pH on the 
enzyme activity. As the pH increases from 5.5 to 8.5 the activity decreases as shown 
in the next graph. When optimizing for the purification steps, buffers with different 
pH values are tried. For measuring the activity levels at different pH values, control 
samples at that pH values must be prepared for each step. 
 
 
Figure 3.28: Effect of pH on the QBP1-lcc1 enzyme activity. 
3.4.6. Optimization for elution buffer 
Different buffers were tried as elution buffers with different detergent ratios and pH 
values. For all samples, PC buffer (pH 7,5) was used as binding buffer and PC buffer 
(pH 6,5) was used as washing buffer. Each elution steps were proceeded in 4 steps 
collecting samples in different tubes for increasing enzyme purity and yield levels. 
The table given below shows Protein Activity, Total Protein Amount, Specific 
Activity, percent yield and fold  levels for each input and eluted samples. Each 
elution buffer is formed basically from PC buffer with different pH levels, detergent 
or chemicals. After using PC buffer (pH.3) for elution step, ~7 fold purification has 
Enzyme 
Activity 
(U/lt) 
pH 
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been obtained but yield was low as 12%. The case looks like similar with using PC 
buffer (pH.4.5), as the fold increases the yield decreases dramatically. The reason for 
using low pH levels for the elution part mainly aims the breaking of the ionic 
interactions.  
In the case of using PC buffer (pH.4.5+ 0,5%Tween 20), fold was lower than the  
previous cases. Overall, increasing protein activity levels might results in better fold 
and yield levels. 
Although strong acid solutions and detergent containing solutions were somewhat 
able to release QBP1 tag from the particles, these conditions could be destructive for 
proteins.  
High concentrations of MgCl2 will also release Sil-tag, even at neutral pH. Divalent 
cations with high ionic potential play an important role in dissociating Sil-tag from 
silica. They are electrostatically attracted to negatively charged silica surfaces.Sil-
tagged proteins on silica surfaces are dissociated by an ion exchange effect, wherein 
Mg 2+ act as competing ions for silanol groups. Moreover, after the dissociation of 
Sil-tag, the divalent cations are expected to bind to the surface silanol group, with 
each alkaline earth metal ion linked to approximately one silanol group as follows: 
-SiOH+M2+  ---SiOM+ + H+ 
This positively charged surface site should neutralize the total surface charge, repel 
the Sil-tag polypeptide with a net positive charge, and therefore prevent re-
adsorption of the released Siltag, resulting in the efﬁcient elution of Sil-tag. So, 
better results were obtained with PC buffer containing MgCl2 (2 M, pH.8). ~60-70% 
yield has been obtained with 6-7 fold purification. 
As in HisTag purification system, imidazole has been tried as an elution agent to 
compete with QBP1 tag. Using imidazole as an elution agent aims the mimic the 
cyclic structure of proline amino acid, which is the main part of QBP1 peptide. The 
binding mechanism of QBP1 might be due to higher percentage of proline residues 
so a similar structure such as imidazol would break the interaction between silica and 
QBP1 peptide. 
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Table 3.7: Eluted protein properties for different elution buffers. 
 
Figure 3.29 shows together the different conditions for QBP1-lcc1 protein 
purification process. Silica (60 to 200 um in diameter) and quartz (200-800 um in 
diameter), were used as resin material. Both materials are cheap and commercially 
available requiring no initial process before the purification steps. They were cleaned 
with isopropanol, ethanol and distilled water in sonic bath and packed in separate 
columns or used as batch system. PC buffer (pH.7,5) was used as binding buffer and 
PC buffer (pH.6,5 + 0.5%Tween20) was used as washing buffer. The extracellular 
protein sample was in PC buffer (pH.7,5) to have the protein in native form, or in PC 
buffer (pH.7,5 + 8M Urea) to have the protein in denatured form, to see the effect of 
protein folding on binding level. The elution buffer was PC buffer (pH4.5, 0,5% 
Tween20).  
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Figure 3.29: SDS-PAGE and native-PAGE results showing the purification steps of 
native or denatured QBP1-lcc1 protein through silica or quartz resins 
with column/ batch procedure. (M:Marker, EC: Extracellular protein 
sample, FT: Flowthrough, W: Wash, E: Elution).The red arrows show 
the QBP1-lcc1 bands. Native gel was applied into ABTS containing 
buffer to observe the enzyme activity.  
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Purification conditions given in Figure 3.29 shows that ”QBP1” peptide is very 
promising as a tag molecule for purification purpose. Each experiment needs some 
more optimization steps but as overall, tag works in native and denatured states of 
the protein and also through silica and quartz resins. Extra bands in Elution sample 
(E) can easily be removed with one extra ultrafiltration step or tuning the pH of 
elution or washing buffers. It is same for denatured cases. Increasing the washing 
steps can increase the purity of eluted protein. 
3.4.7. QBP1 as a TAG peptide 
Paramaters to select a Tag system: During the last 25 years many alternative 
affinity tag systems have been described, all having advantages and disadvantages 
depending on the application and the requirement for specificity, solubility, and the 
binding and elution conditions. No single affinity tag is optimal. Depending on the 
structure and the procedure, each has weak and strong sides (Nilsson et al. 1997, 
Hearn et al. 2001, Terpe et al. 2003, Arnau et al. 2006, Lichty et al. 2005, Waugh et 
al. 2005).  
To select a suitable tag system for the purification of a desired biomolecule, there are 
some parameters which must be considered beforehand.  
The first parameter is the the translation efficiency. The tag molecule can be placed 
at N or C terminal of the protein or inside the protein where a permissive site occurs. 
A suitable tag molecule must not decrease the efficiency of translation.  In general, 
bigger tag molecules (protein tags) such as MBP or GST tags are known as having 
less effect on translation efficiency. These tags are already naturally translated 
proteins and they do not interfere with the translation process of the fusion protein. In 
contrast, depending on the amino acid sequence, short peptides can decrease the 
efficiency of the translation process.  In this case, tag peptide must be located at C 
terminal of the protein or somewhere permissive on the protein, if the interaction 
between tag peptide and the resin material is not been blocked (Lichty et al. 2005). 
The second parameter is the metabolic burdendue to using bigger protein tags. Using 
short peptides does not cause any extra metabolic burden for the host cell but protein 
tags can be as large as the functional protein which is intented to be purified. So, the 
cell needs to translate a whole tag protein too which causes a metabolic burden for 
the host cell.  
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The third parameter is the specificity of the tag molecule to the resin material. 
Peptide tags such as the FLAG-tag (Nilsson et al. 1997), the calmodulin-binding 
peptide (Hearn et al. 2001), the Strep-tag or Streptag II (Terpe et al. 2003, Arnau et 
al. 2006) and the biotin acceptor peptide (Hochuli et al. 1987) have a high degree of 
specificity for their binding resin partners.  On the other hand, the resins for these 
short peptide tags are generally expensive and have low binding capacities.  
The fourth parameter is whether tag molecule enhances solubility of the fusion 
molecule or not. For most of the applications, tagged protein is better to be in soluble 
form instead of forming insoluble inclusion bodies which needs extra steps to be 
solubilized. In general, protein tags are known better enhancers for a soluble tagged 
protein. For short peptide tags, the peptide sequence of the tag and the location of the 
tag on the protein must be considered beforehand which will be effective on the 
solubility of the fusion protein. 
Resin price, mild elution conditions and easiness of the protocol are some other 
parameters to be considered. These are the parameters which are necessary to be 
considered before the experimental procedure. A peptide or protein tag may have 
high specificity and less metabolic burden for the cell or other advantageous sides 
but relatively expensive resins may make the system useless for most applications.  
Main objective of the purification is obtaining the tagged protein unharmed and still 
active at the end of the process. That is why, using mild elution conditions as HisTag 
system uses (100–250 mM imidazole, pH: 5.0, or 10 mM EDTA) would be critical 
step. And finally, easiness of the purification protocol especially one step purification 
must be aimed.   
Additionally, because affinity tags have the potential to interfere with structural or 
functional studies, removing them may be necessary at the end of the purification 
process. If the tag molecule does not interfere with the activity or structure of the 
purified protein, depending on the application, it may stay fused to the purified 
protein but for most of the tag systems, especially for protein tags, extra steps must 
be added to the purification protocol to remove the the tag.  
QBP1 as a “tag” peptide: Here, we are presenting a methodology of designing your 
own TAG peptide for any desired resin material. QBP1 is a silica/quartz binding 
peptide which is 12 amino acid long (PPPWLPYMPPWS), and it has been developed 
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by combining the combinatorial and bioinformatic techniques. So, the first advantage 
is the flexibility of designing a new peptide system. QBP1 works good as a tag 
peptide, but if necessary, the flexibility of methodology enables you using other 
quertz binders (QBP2, QBP3 etc.) or selecting new tag peptides for any other resin 
material.  
The purification protocol for QBP1-tag system is relatively easy and simple. There is 
no need for extra purification steps, single step elution is possible. The resin material 
can be quartz, silica or even crushed glass which do not need for any prior activation 
steps. No peptide, metal ion or any ligand must bind on the resin. The ligand for the 
tag is already the resin material itself. So, after cleaning the resin, it is ready to be 
used for the binding.  
Purification protocols are also flexible. The tagged protein can be purified in native 
or denatured form depending on the later application in which the purified protein is 
needed. Also, batch or column protocols are available for the process. Different 
elution buffers were tried and in general mild elution conditions were available for 
the purification protocol such as neutral pH, low salt conditions or addition of MgCl2 
(2 M).  
Using SilTAG is much less expensive than conventional afﬁnity puriﬁcation 
methods, which require a ligand to be immobilized on a resin, because the silica 
itself serves as both a resin and ligand for SilTAG. On the basis of costs reported by 
Lichty et al. (2005), our method is one of the least expensive of several commonly 
used methods for isolating tagged proteins; the cost was approximately $3 per 10 mg 
of total protein using silica particles (calculated from the retail price of $1.2 per gram 
dry weight of the particles used), whereas the conventional methods cost $12 to 
$5000 to purify the same amount of tagged polypeptide. 
QBP1 has no effect on the enzyme activity which makes extra purification steps 
unnecessary. Simply, the tag can be left on the enzyme. If necessary, it can be 
cleaved off via Factor Xa cutting site. This is one of the generally used the strategies 
of removing tag molecule from the purified protein. 
Because it is short peptid, it causes no metabolic burden for the host cell but 
depending on the cell type, protocol must be formed carefully. Results show that in 
eukaryotic host cell, there is no problem about the translation efficiency but in 
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bacterial host cells, the tag peptide may be interfering with the translation process.  
This is most possibly due to the amino acid sequence of the peptide. the provisions to 
overcome the problem might be locating the tag molecule at C terminal of the 
protein, using eukaryotic host cell or changing to another quartz binding peptide.    
8 fold purification with the level of 60% yield is obtained using MgCl2 as the elution 
material. 
Overall, what we are showing here is that Molecular Biomimetics and bioinformatic 
tools, collectively, offer a good way of designing our own tag peptide for purification 
purposes with increased properties and QBP1 can be used as a tag molecule 
successfully.  
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3.  CONCLUSION AND RECOMMENDATIONS 
The experiments previously carried out showed us that QBP-1 peptide is a strong 
silica-binder which makes it suitable for medical and nanobiotechnological 
applications via making available the formation of fusion proteins. One of the 
applications is using the QBP-1 peptide as a tag peptide for the isolation of any 
desired protein. 
The selection procedure of Quartz Binding Peptides was simply as followed; firstly, 
Phage Display Methodology was used for the selection of quartz binding peptides. 
Library of M13 phages (~10
9
 colonies/ml) each containing random 12 amino acid 
peptide sequences at N-terminal of one of the coat proteins, P3. After 5 biopanning 
cycles, 50 first generation quartz binding peptides were isolated which then, grouped 
into 3 groups as strong, moderate and weak binders according to their binding 
strengths by using semi-quantitative fluorescence microscopy experiments. Next step 
was taking the strong binders’ properties and designing theoretical binders by using 
bioinformatics tools. These were the second generation quartz binding peptides 
which then top six of the strong binders were experimentally produced and their 
binding strengths were verified. QBP1 peptide sequence was the top one among the 
second generation theoretically designed binders. 
Using QBP1as a tag peptide for biomolecule purification purpose is composed of 
two main parts. The first one is the formation of QBP1 tagged functional proteins at 
the DNA level and then expression of these molecules in prokaryotic or eukaryotic 
cell lines.  
QBP1 peptide was designed and placed at the N terminal of functional proteins 
which were recombinant green fluorescent protein (GFPuv) and alkaline phosphatase 
(AP) protein. DNA construct included necessary restriction enzyme cutting sites, 
spacer sequence, Factor Xa cutting site for later protease cutting purpose. Different 
versions of cloning and expression vectors were formed for each functional proteins. 
The constructs were formed suitable for later replacement of any desired protein or 
tag molecule. All the sequences were verified by sequencing analysis to prevent any 
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mutation occurence which would affect the expression steps severely. QBP1-GFPuv 
construct was transformed into different prokaryotic cells for expression analysis. 
The construct was loosely expressed which was generally unrepeateble. Different 
media conditions, vector choices, time and IPTG ranges had not affect the level of 
expression. QBP1-AP construct case had the similar problems. But at the end, the 
construct was formed incompletely, about 42 kDa instead of 51 kDa fusion protein. 
For both QBP1-GFPuv and QBP1-AP cases, the problems affecting the expression 
levels might be most possibly about the amino acid composition of QBP1 sequence. 
QBP1 is located at the N-terminal of the functional proteins. During the translation 
process, it is produced first, then the functional produced as a fusion molecule. There 
are many prolin residues in QBP1 sequence, especially the first three residues, which 
might be the reason of a loop formation and incomplete ending of protein translation 
process in QBP1-AP or complete loss of QBP1-GFPuv expression. Expressed QBP1-
AP construct protein was purified using silica columns and a clear 42 kDa band has 
been obtained. That shows us QBP1 is produced properly and binds on silica surface 
through the column but the remaining AP protein is not properly expressed. These 
results show the importance of selection process for QBP sequence for prokaryotic 
protein purification process. QBP1 sequence can be located at the C-terminal end of 
the fusion protein or another quartz binding peptide which have been selected 
computationally and enhanced via bioinformatic techniques can be easily replaced 
with QBP1 sequence.        
For eukaryotic expression of QBP1 tagged functional protein, we constructed a 
QBP1-lcc1 fusion molecule, first on the DNA level, and expressed it to show the 
enzyme activity. DNA sequences were verified before protein expression steps. The 
problems which occured with prokaryotic expression systems did not occur and 
QBP1-lcc1 functional protein was produced properly. The first result here is that, 
QBP1 does not affect the expression of the construct protein as it happens in 
prokaryotic cells. Secondly, the construct was successfully sent to the extracellular 
space whic means that QBP1 tag molecule does not affect the secretion of the 
construct molecule extracellularly. Finally, the tagged protein has the same level of 
enzyme activity with the control bare lcc1 protein. That means QBP1 tag does not 
affect functioning of the protein and it can be left on lcc1 protein after purification 
process which eliminates the following purification steps.  
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At the end of the first part, a set of GEPI-Functional Protein Constructs have been 
formed for bacterial and eukaryotic cells. QBP1-GFPuv, QBP1-AP and QBP1-lcc1  
constructs with/out linker sequences for 4 different cell types and in 12 different 
vector form for them were formed. QBP1-lcc1 fusion protein was expressed 
successfully. The fusion protein was secreted extracellularly and activity of the 
enzyme was ensured.    
The second part of the study was using the QBP1 peptide as the “TAG” molecule for 
purification of lcc1from extracellular cell medium through silica/quartz packed 
columns. The results show that QBP1 is a very promising tag molecule which have 
the main advantageous sides. The purification protocol for QBP1-tag system is 
relatively easy and simple. Single step elution is possible making the purification 
protocol time saving and simple. The resin materials, quartz, silica and glass, do not 
need any prior steps for surface activation, ready to use after cleaning and relatively 
much more cheaper than other resins for commercially available tag systems. 
QBP1 has no effect on the secretion of enzyme extracellularly or enzyme activity  
which makes extra purification steps unnecessary. Simply, the tag can be left on the 
enzyme according to the application in which the purified protein is needed.  
Batch or column protocols are available for the purification of tagged protein both in 
native or denatured forms. By tuning the pH levels of binding, washing and elution 
buffers, or using extra chemicals to compete with QBP1 peptide on binding, a better 
purification level was obtained. Among the different elution buffer selections, MgCl2 
(2 M, pH: 7.5) containing buffer gave a better result with 8 fold purification with 
60% yield level.  
Overall, Molecular Biomimetics gives us a way to select our own tag peptide for any 
desired inorganic material which can be used in prokaryotic or eukaryotic cell types, 
in different purification protocols and protein folds. It is very important to get the 
protocol strategy as a principle for any new desired application. And finally, QBP1 
can be used as a tag molecule successfully. 
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APPENDIX A.1 :  
Sequence Landmarks of pETBlue-2 Vector  
Element     Position (bp) 
Lac operator     3606–3625 
T7 promoter     1–17 
Lac operator     22–42 
T7 transcription start    18 
Multiple cloning region   276–467 
(Nco I–Pac I) 
His•Tag® coding sequence   437–454 
HSV•Tag® coding sequence  395–430 
LacZ start codon    491 
LacZ α-peptide ORF    57–491 
E. coli promoter    541–569 
F1 origin     1096–1551 
Bla coding sequence    1669–2526 
pUC origin     3206 
 
 
Figure A.1 : Multiple Cloning Sites (MCS) on pETBlue2 vector.  
 
 
 
107 
APPENDIX A.2 :  
Sequence Landmarks of pCR
®
2.1-TOPO
®
 Vector 
Element    Position (bp)  
LacZα fragment    1-547    
M13 reverse priming site   205-221 
Multiple cloning site    234-357 
T7 promoter/priming site   364-383 
M13 Forward (-20) priming site  391-406 
F1 origin     548-985 
Kanamycin resistance ORF   1319-2113 
Ampicillin resistance ORF   2131-2991 
pUC origin     3136-3809 
 
 
 
Figure A.2 : Multiple Cloning Sites (MCS) on pCR2.1-TOPO vector.  
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APPENDIX A.3 :  
Sequence Landmarks of pPICZ-B Vector 
 
 
 
 
 
Figure A.3 : Multiple Cloning Sites (MCS) on pPICZ-B vector.  
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APPENDIX A.4 :  
Sequence Landmarks of pGEM-T Easy Vector 
 
 
 
 
Figure A.4.: pGEM®-T Easy Vector Map and Sequence Reference Points. 
 
 
110 
 
APPENDIX A.5 :  
Sequence Landmarks of pQE-60 Vector 
 
 
 
 
Figure A.5.: pQE-60 Vector Map and Sequence Reference Points. 
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APPENDIX B.1 :  
Laccase (lcc1) mRNA sequence from Pycnoporus sanguineus (1557 bp) 
 
5’- 
ATGGGCTCCGGTCTTTTCAGCATCTTCGTCACCATCGCGGCCATCTCTGG
CAGCCTCGCTGCCATCGGGCCCAAGGCGGACCTCGTCATCTCGGACGCTG
TCGTCAATCCTGATGGCACGCCCCGAGCTGCCGTCGTCGTTAATGGCGCA
TTCCCTGGCCCCCTCATCTCTGGGAAGAAGGGTGATCACTTCCAGCTCAA
CGTGATCAACAAGTTGACCAACCACACTATGCTGAAGACGACCAGTATA
CACTGGCACGGACTTTTCCAGGAACACACTAACTGGGCTGACGGTCCCGC
TTTCGTCAATCAATGTCCCATTGCTTCTGGACACTCCTTCCTCTACGACTT
CCATGTGCCCGATCAAGCCGGCACATACTGGTACCACAGCCATCTTTCCA
CGCAGTACTGCGACGGATTGAGAGGGCCGCTTGTCGTGTACGACCCCCAC
GATCCTCAGGCGCATCTGTATGATGTTGACAACGATGACACTGTCATCAC
TTTGGCGGATTGGTATCATGTCGCGGCCAAGCTAGGCCCGCAATTCCCGA
GGGGCGCAAACTCTACGCTCATCAACGGCCTTGGACGAGCGGCGACTGA
TAGCACTTCCGATCTCAGTGTCATTACCGTTGAGCATGGGAAGCGCTATC
GTTTCAGGCTTGTATCCATCTCTTGTGATCCGAACCACACCTTCAGCATCG
ATGGCCACAACATGACCATCATCGAAGTCGATGGCGTCAACAGCAAGCC
CCTCACCGTCGACTCCATCCAGATTTTCGCAGCCCAGCGCTACTCCTTCGT
GTTGAATGCTAACCAACCGGTGGACAACTACTGGATTCGTGCGAATCCGA
GTGGCGGAACCGTGGGTTTCGAGGGCGGCATCAACTCTGCCATTCTCCGA
TACAAGGGTGCGCCGGATGCCGAGCCCACGAACACGACCGCGCCGACAT
CTGTCATTCCTCTGGTGGAGACGAATTTGCACCCCCTCAAGCCGATGCAA
GTGCCCGGCCGGTCTGGTGTCGGTAACGTTGATTATGCGAAGACACTCAA
TTTCAACTTCAACGGCACCAACTTTTTCATCAACAATGCGACGTTCACCC
CGCCCACAGTCCCCGTCCTCCTCCAGATCCTGAGCGGAGCGCACAACGCG
CAGGACCTCCTCCCCGCCGGGTCTGTTTACACTCTTCCGCCGCACAGCGC
CATCGAGATTACCATGCCGGCTACTACCCTAGCCCCGGGATCTCCCCACC
CCTTCCACTTGCACGGGCACGTCTTCGCTGTCGTACGCAGCGCCGGCAGC
ACCGAGTACAACTACCACGACCCCATCTTCCGCGACGTCGTGAGCACCGG
CCAGCCCGGCGACAGCGTCACGATCCGGTTCATGACGGACAACCCGGGT
CCGTGGTTCCTCCATTGCCACATCGACTTCCATCTCGAGGCCGGCTTCGCC
ATCGTGTTTGCCGAGGACGTGAACGATATCAAGTATGCGAACCCGGTCCC
GCCGTCGTGGTCGGAGCTTTGCCCCATCTACGACAAGCTCCCGGAGTCCG
ACCATTAG-3’ 
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APPENDIX B.2 :  
 
Alkaline phosphatase DNA sequence (1434 bp): 
 
5’-
GTGAAACAAAGCACTATTGCACTGGCACTCTTACCGTTACTGTTTACCCC
TGTGACAAAAGCCCGGACACCAGAAATGCCTCTGCAGTAGGCGCTCGAG
GTTCTGGAAAACCGGGCTGCTCAGGGCGATATTACTGCACCCGGCGGTGC
TCGCCGTTTAACGGGTGATCAGACTGCCGCTCTGCGTGATTCTCTTAGCG
ATAAACCTGCAAAAAATATTATTTTGCTGATTGGCGATGGGATGGGGGAC
TCGGAAATTACTGCCGCACGTAATTATGCCGAAGGTGCGGGCGGCTTTTT
TAAAGGTATAGATGCCTTACCGCTTACCGGGCAATACACTCACTATGCGC
TGAATAAAAAAACCGGCAAACCGGACTACGTCACCGACTCGGCTGCATC
AGCAACCGCCTGGTCAACCGGTGTCAAAACCTATAACGGCGCGCTGGGC
GTCGATATTCACGAAAAAGATCACCCAACGATTCTGGAAATGGCAAAAG
CCGCAGGTCTGGCGACCGGTAACGTTTCTACCGCAGAGTTGCAGGATGCC
ACGCCCGCTGCGCTGGTGGCACATGTGACCTCGCGCAAATGCTACGGTCC
GAGCGCGACCAGTGAAAAATGTCCGGGTAACGCTCTGGAAAAAGGCGGA
AAAGGATCGATTACCGAACAGCTGCTTAACGCTCGTGCCGACGTTACGCT
TGGCGGCGGCGCAAAAACCTTTGCTGAAACGGCAACCGCTGGTGAATGG
CAGGGAAAAACGCTGCGTGAACAGGCACAGGCGCGTGGTTATCAGTTGG
TGAGCGATGCTGCCTCACTGAATTCGGTGACGGAAGCGAATCAGCAAAA
ACCCCTGCTTGGCCTGTTTGCTGACGGCAATATGCCAGTGCGCTGGCTAG
GACCGAAAGCAACGTACCATGGCAATATCGATAAGCCCGCAGTCACCTG
TACGCCAAATCCGCAACGTAATGACAGTGTACCAACCCTGGCGCAGATG
ACCGACAAAGCCATTGAATTGTTGAGTAAAAATGAGAAAGGCTTTTTCCT
GCAAGTTGAAGGTGCGTCAATCGATAAACAGGATCATGCTGCGAATCCTT
GTGGGCAAATTGGCGAGACGGTCGATCTCGATGAAGCCGTACAACGGGC
GCTGGAATTCGCTAAAAAGGAGGGTAACACGCTGGTCATAGTCACCGCT
GATCACGCCCACGCCAGCCAGATTGTTGCGCCGGATACCAAAGCTCCGG
GCCTCACCCAGGCGCTAAATACCAAAGATGGCGCAGTGATGGTGATGAG
TTACGGGAACTCCGAAGAGGATTCACAAGAACATACCGGCAGTCAGTTG
CGTATTGCGGCGTATGGCCCGCATGCCGCCAATGTTGTTGGACTGACCGA
CCAGACCGATCTCTTCTACACCATGAAAGCCGCTCTGGGGCTGAAATAA-
3’ 
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APPENDIX B.3 :  
Mutant Green Fluorescent Protein (GFPuv) DNA Sequence (717 bp): 
5’-
ATGAGTAAAGGAGAAGAACTTTTCACTGGAGTTGTCCCAATTCTTGTTGA
ATTAGATGGTGATGTTAATGGGCACAAATTTTCTGTCAGTGGAGAGGGTG
AAGGTGATGCAACATACGGAAAACTTACCCTTAAATTTATTTGCACTACT
GGAAAACTACCTGTTCCATGGCCAACACTTGTCACTACTTTCTCTTATGGT
GTTCAATGCTTTTCCCGTTATCCGGATCATATGAAACGGCATGACTTTTTC
AAGAGTGCCATGCCCGAAGGTTATGTACAGGAACGCACTATATCTTTCAA
AGATGACGGGAACTACAAGACGCGTGCTGAAGTCAAGTTTGAAGGTGAT
ACCCTTGTTAATCGTATCGAGTTAAAAGGTATTGATTTTAAAGAAGATGG
AAACATTCTCGGACACAAACTCGAGTACAACTATAACTCACACAATGTAT
ACATCACGGCAGACAAACAAAAGAATGGAATCAAAGCTAACTTCAAAAT
TCGCCACAACATTGAAGATGGATCCGTTCAACTAGCAGACCATTATCAAC
AAAATACTCCAATTGGCGATGGCCCTGTCCTTTTACCAGACAACCATTAC
CTGTCGACACAATCTGCCCTTTCGAAAGATCCCAACGAAAAGCGTGACCA
CATGGTCCTTCTTGAGTTTGTAACTGCTGCTGGGATTACACATGGCATGG
ATGAGCTCTACAAATAA-3’ 
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APPENDIX C.1   
 
1) Single Strand DNA oligo including Enzyme Cutting Sites+QBP1+14 aa 
linker+ Factor Xa Cutting Site: 
   
                                                                                                                                                                              
5’-
GCTGACGTTGGAAGATCTTCAAGGAGATATACCATGCCGCCGCCGTGGCT
GCCGTATATGCCGCCGTGGAGCGGATCCCCGCCGCCGGGCCCGCCGGGC
CCGCCGCCGGGCCCGCCGCCGATTGAAGGCCGTGGAATTCATGGCATCG-
3’ 
 
Primers for ssDNA amplification: 
 
Forward Primer: 5’- GCTGACGTTGGAAGATCTTCAAGGAGA-3’ 
 
Reverse Primer: 5’-CGATGCCATGGAATTCCACGGCCTTCA -3’ 
 
2) Oligo DNA Primer without linker:  
 
5’-
TACCATGGCGCCGCCGCCGTGGCTGCCGTATATGCCGCCGTGGAGCATTG
AAGGCCGTGGAATTCAG  -3’ 
 
 
Reverse Primer: 5’- AACAAGCTTTTATTTCAGCCCCAGAGCGG   -3’ 
 
 
3) Primers for Alkaline phosphatase amplification from pSB2991; 
 
Forward Primer:  
5’-GCTGGAATTCAGGTGAAACAAAGCACTATTGCACTGGC-‘3 
               
Reverse Primer: 
 
5’- AACCTGCAG-TTATTTCAGCCCCAGAGCGG   -3’ 
 
 
4) Primers for QBP1-Alkaline Phosphatase amplification: 
 
Forward Primer:  
 
5’-CCATGGTGAAACAAAGCACTATTGC-3’  
 
QBP1a primer: 
 
5’-CCACGGCGGCGGGAATTCACGGCCTTCAATTTTCAGCCCCAGAGCGG-
3’ 
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QBP1b primer: 
 
5’-
AAGCTTTTATTAGCTCCACGGCGGCATATACGGCAGCCACGGCGGCGGG
AATTC-3’ 
 
5) Primers for QBP1-GFPuv fusion molecule. 
Forward Primer: 
5’-CCA CGG CGG CAT ATA CGG CAG CCA CGG CGG CGG CAT-3’ 
Reverse Primer: 
5’-CTG CCG TAT ATG CCG CCG TGG AGC CCG CCG CCG GG-3’ 
6) Primers for QBP1-lcc1 fusion molecule. 
Forward Primer:  
5’-
GAATTCAGCATGCCACCACCATGGTTGCCATATATGCCACCATGGTCTAT
TGAAGGTAGAGGCTCCGGTCTTTTC-3’ 
Reverse Primer: 
5’-AACGCGGCCGCCCTAATGGTCGGACT -3’ 
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Appendix D. 
Molecular Weight Markers 
 
1)       2)                     3)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A. 6.: DNA Molecular Weight Markers. 
1)  ΦX174 DNA HinfI digested marker-10, 2.5% agarose, 0.5µg/lane, 8 cm length 
gel, 1X TBE, 5V/cm. (Catalog # SM0261, NBI Fermentas). 
2)  λ DNA EcoRI and HindIII digested marker-3, 1.0% agarose, 0.5µg/lane, 8 cm 
length  gel, 1X TAE, 17V/cm. (Catalog # SM0191, NBI Fermentas). 
3)  ΦX174 DNA BsuRI digested marker-9, 1.7% agarose, 0.5µg/lane, 8 cm length 
gel, 1X TBE, 5V/cm. (Catalog # SM0251, NBI Fermentas). 
 
Figure A. 6.: Unstained Protein Molecular Marker. 
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